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Preamble 
 
Nowadays, there are antithetic perceptions of the distribution of pathogenic organisms worldwide. 
Based on increased hygiene standards, parasitic infections are no longer considered as a 
common health problem in industrial nations. Instead, during the last decades allergies, 
autoimmune and metabolic disorders like diabetes are new representatives of our modern life. 
This situation is in part explained by the extended hygiene hypothesis. In industrialized countries, 
parasitic infections are mostly limited to children infected with head lice or pin worms and to 
domestic animals. However, parasitic infections represent enormous health problems in tropical 
and subtropical regions in Africa, South America and Asia. Thus, programs to eradicate different 
parasitic infections like lymphatic filariasis or onchocerciasis have been launched by the World 
Health Organization (WHO) to intensify the efforts in the development of new treatments on these 
long neglected tropical diseases.  
Furthermore, helminth parasites modify the immune system to ensure their long-term survival and 
distribution in the hosts. This kind of mechanism is termed immunomodulation and comprises 
nearly all fields of immunology but also genetics. The immunoregulatory and immunogenetic 
mechanisms of the host protection but also the regulatory protective effects of helminth infections 
on inflammatory disorders are not fully understood yet.  
Motivated by the fascinating contrary impact of helminth infections on inflammation this work is 
not limited to experimental results on the protective effect of eosinophil granulocytes against E. 
coli induced sepsis in mice. We also performed a genome-wide transcriptional profiling of human 
non-endemic monocytes to analyze the impact of a human pathogenic filarial crude antigen 
extract on the following LPS stimulation. We identified immunomodulatory effects that are linked 
to IL-17 driven diseases like psoriasis, arthritis or allergy but also atherosclerosis.  
Therefore, the work of this thesis provides not only new insights to filarial host-pathogen-
interactions but also more information on the protective effects and cutting points on inflammatory 
immune responses and genomics termed immunomics. Further investigations are needed to 
analyze the genetic impact on the expression profiles in response to helminth products that are 
necessary to personalize treatments.  
 
Yours sincerely, 
 
Benedikt Bürfent  
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Summary 
 
Human filarial nematode infections cause lymphatic filariasis and onchocerciasis in more than 
150 million people worldwide. An infection can result in debilitating clinical manifestations like 
visual impairment or lymphedema that lead to socioeconomic problems and is therefore listed by 
the World Health Organization for elimination. Principally, filariae modulate cellular immune 
responses for long-term survival in their host and this modulation of the host’s immune response 
also dictates the occurrence of host pathology. Helminth infections and helminth-derived products 
can furthermore modify host immune responses to protect against inflammatory and autoimmune 
diseases. For instance, we previously provided evidence that infection with the rodent filarial 
nematode Litomosoides sigmodontis, a well-accepted model to study immune responses during 
filariasis, improves sepsis outcome without worsen immune paralysis and protects against 
autoimmune and type 2 diabetes.  
Since eosinophil granulocytes are a hallmark of helminth infections we examined the impact of 
murine eosinophils against Escherichia coli-induced sepsis and the effect of the specific 
chemoattractants eotaxin-1 and 2 (CCL11 and CCL24) on the release of sepsis-relevant 
cytokines and chemokines of bone-marrow-derived eosinophils (bmEos). We identified eotaxin-2 
(CCL24) to modify the interleukin (IL)-4 response after LPS, P3C and L. sigmodontis crude extract 
stimulation and to alter the expression of the eotaxin receptor C-C chemokine receptor type 3 
(CCR3). The intercellular adhesion molecule 1 (ICAM-1) was not affected by CCL24 treatment. 
In vivo relevance of eosinophils during the course of a bacterial sepsis was demonstrated using 
eosinophil-deficient ∆dblGATA mice. Those mice had an exacerbated sepsis outcome with 
increased pro-inflammatory IL-6 and CXCL2 levels, worsened hypothermia and reduced numbers 
of adaptive and innate immune cells six hours after E. coli challenge compared to wildtype 
controls. Co-cultivation of bmEos and E. coli highlighted the potential to reduce of the bacterial 
burden in vitro via the formation of NET-like extracellular structures and phagocytosis. Initial 
results of a transcriptome-wide analysis of sorted SiglecF+ eosinophils revealed a L. sigmodontis-
dependent but E. coli-independent effect on eosinophil modulation.  
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We furthermore investigated the immunomodulatory effect of the crude extract of the human 
pathogenic filaria Brugia malayi (BmA) on the transcriptome of purified human CD14+ monocytes 
derived from twenty healthy male European non-endemic volunteers. Based on a genome-wide 
transcriptional profiling more than 47.000 transcripts of monocytes stimulated with BmA, E. coli 
lipopolysaccharide ultrapure (LPS) or a successive stimulation of both were analyzed. Several 
genes were identified that were differentially expressed upon BmA priming before LPS re-
stimulation including genes like PTX3↓, MMP9↑, CXCL5/ENA-78↑, CXCL6/GCP-2↑, 
CXCL7/PPBP↑, and CCL20/MIP3α↓. Quantification of CXCL5 and CXCL6 protein levels 
confirmed our results. Lower expression levels of HLA-DR and CD86 on BmA primed monocytes 
were further detected by flow cytometry. BmA-only stimulation reduced the frequency of apoptotic 
cells whereas pre-stimulation did not alter apoptosis after LPS stimulation. Accordingly, Ingenuity 
Pathway Analysis (IPA) © of the transcriptome of monocyte LPS responses in dependence on 
BmA-priming depicted associations in immune functions and inflammatory disorders like 
granulocyte and agranulocyte adhesion, diapedesis and atherosclerosis. Notably, BmA treatment 
affected several IL-17-dependent pathways like signaling in psoriasis, arthritis and allergic 
inflammatory airway diseases.  
Thus, exposure of human monocytes and murine eosinophils to filarial extracts modifies 
inflammatory immune responses and affects the response to subsequent stimuli. This 
immunomodulation may not only impact the development of filaria-caused pathology in humans, 
but may also affect bystander immune responses that contribute to dysregulated immune 
responses as they occur during autoimmunity or inflammation during sepsis. Since earlier results 
indicate that specific gene variants are associated with the severity of pathology, genome-wide 
analysis of expression quantitative trait loci (e²QTL) will further point out regulatory gene variants 
that are correlated with differential expressed transcripts and may reveal new targets for treatment 
strategies against lymphatic filariasis and dysregulated immune responses.   
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Introduction 
 
Parasites are pathogenic organisms that are evolved in different phylogenetic taxonomies with 
variable phenotypes and are per se creatures that live at the expense of a host. Most parasitic 
infections are a phenomenon of optimal adaption to the prevailing conditions, which allows their 
survival and distribution. In general, parasites can be divided by their lifestyles into the two groups 
of ectoparasites and endoparasites. Human parasitic infections present a major health problem 
and are under particular advertency of the World Health Organization (WHO). Human bacterial 
infections that lead to sepsis are furthermore a leading cause of critical illness and death 
worldwide. Analyzing immunomodulatory mechanisms from parasitic helminths may contribute to 
the identification of novel targets and strategies to eliminate filarial infections and to treat 
autoimmune and inflammatory diseases. 
 
1.1 Human pathogenic parasites 
 
In humans, two main groups of endoparasites are described that can induce pathology:  protozoa 
(Sarcodina like Entamoeba spp., Mastigophora like Giardia spp. or Leishmania spp., Sporozoa 
like Plasmodium spp.) and helminths like flatworms (Platyhelminthes including Trematoda (flukes) 
and Cestoda (tapeworms)), thorny-headed worms (Acanthocephala) and roundworms 
(Nemathelminthes). Common members of nemathelminths are rotifer (Rotifera), 
acanthocephalans (Acanthocephala), horsehair worms (Nematomorpha) and threadworms 
(Nematoda) (Lucius et al., 2017). Basically, protozoans comprise pathogens like Leishmania 
tropica (leishmaniasis), Trypanosoma cruzi, T. brucei (trypanosomiasis), Toxoplasma gondii 
(toxoplasmosis) as well as Trichomonas vaginalis (trichomoniasis) and infections can result in a 
strong humoral immune response of the host (Baron, 1996). Particularly, infections by 
Plasmodium falciparum, a member of Plasmodiidae that causes malaria, induce strong 
inflammation with non-cyclic fever and cerebral malaria with severe neurological symptoms that 
often result in death (Bartoloni and Zammarchi, 2012). In addition, Entamoeba histolytica 
infections can induce abscesses in the lung and the liver, diarrhea and ulceration (Baron, 1996). 
Helminth infections lead to chronic infections and fatal cases are e.g. described for infections by 
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Schistosoma spec. (schistosomiasis) and Echinococcus multilocularis (Burke et al., 2009; Eckert 
and Deplazes, 2004). Helminth is a medical term describing worms of different phylogenies with 
a multi-faceted phenotype. Infections with gastrointestinal helminths like Ascaris lumbricoides 
(ascariasis), Trichuris trichiura (trichuriasis) and hookworms belong to the soil-transmitted 
helminth infections and can cause diarrhoea, abdominal pain, malnutrition and anemia (Guyatt 
and Bundy, 1991; Mishra et al., 2014). Infections with filarial nematodes can cause severe 
pathologies like skin-disease and blindness (Onchocerca volvulus infection, onchocerciasis) or 
chronic lymphedema (Wuchereria bancrofti, Brugia malayi or Brugia timori infection, elephantiasis 
or hydrocele) (Taylor et al., 2010). Helminth infections often last over several years and 
dependent on the species, the pathogens can persist either in the gastrointestinal tract, blood, 
lymphatic system or subcutaneous tissues of their hosts.  
Several arthropods are representatives of ectoparasites that can live temporarily or permanently 
on the host (Lucius et al., 2017). Blood-feeding ectoparasites serve as vectors for the 
transmission of endoparasites such as Plasmodium or filariae. Due to co-evolutionary adaption 
filarial nematodes like Mansonella perstans are closely adapted to their hosts and environments. 
This interdependency and host-specificity ensures long-time survival, reproduction and 
transmission and is based on a host-immunity manipulation termed immunomodulation. 
Accordingly, poorly adapted parasites like P. falciparum or E. multilocularis cause severe 
pathologies in humans. Parasitic infections are a major global health problem that may cause life 
threatening diseases, severe morbidity and chronic debilitating diseases. 
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1.1.1 Helminth-driven human diseases – lymphatic filariasis and onchocerciasis 
 
More than 150 million people are infected worldwide by human pathogenic filarial nematodes 
causing lymphatic filariasis and onchocerciasis (WHO, 2016a, b). Wuchereria bancrofti, Brugia 
malayi and Brugia timori are transmitted by bloodsucking mosquitos causing lymphatic filariasis 
(LF) in approx. 120 million people. In addition, Onchocerca volvulus leads to approximately 30 
million cases of onchocerciasis. Co-endemicity was reported also for Loa Loa and Mansonella 
perstans (Gardon et al., 1997; Keiser et al., 2003). Onchocerciasis mainly occurs in sub-Saharan 
Africa and LF is distributed in tropical and sub-tropical regions worldwide, representing a global 
health problem of common developing countries with a low economic standard and causing 
socioeconomic problems (Fig. 1). With an incidence of almost 90% Wuchereria bancrofti 
infections represent the most prominent cause of LF (Michael et al., 1996) especially in Africa but 
also in Middle and South America. Brugia malayi infections are described for south and south-
west Asia that represent nearly 10% of all LF cases followed by Brugia timori infections, which 
are found in Indonesia.  
 
Figure 1: Global programme to eliminate lymphatic filariasis: progress report, 2015. Countries where lymphatic filariasis is 
endemic and status of mass drug administration (MDA) is shown (WHO 2016). 
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The life cycle of Wuchereria bancrofti and Brugia spp. (Lymphatic filariasis) 
Published by Patrick Manson in 1878, infectious stage-3 larvae (L3 larvae) of W. bancrofti or 
Brugia spp. are transmitted to humans during the blood meal of mosquitos into humans 
(Culicidae; e.g. Anopheles spp. in Africa, Culex spp. in America and Aedes spp. in Asia and pacific 
areas) (Manguin et al., 2010; Manson, 1878). Following two molting steps the larvae become 
adult and persist in the lymphatics where they produce microfilariae (mf) and cause pathology. 
When the microfilariae reach the blood stream, mosquitos can take them up. Within the mosquito 
the microfilariae penetrate the midgut and migrate to the thoracic muscles, where they moult from 
stage-1 larvae (microfilariae) to infectious L3 larvae. Afterwards, they migrate to the proboscis of 
the mosquitos for transmission during the next blood meal (Fig. 2).  
 
Figure 2: Brugia malayi life cycle as example for human filarial infection. After L3 larvae transmission during the blood meal of 
mosquitos, the larvae become adult in the lymphatics and produce microfilariae that are transmitted with the next blood meal of 
the vector. Taken up by the vector, the microfilariae migrate to the thoracic muscles and become L3 larvae. The L3 larvae migrate 
to the mosquito’s proboscis and infect the host during the next blood meal. Illustration by CDC/Alexander J. da Silva, PhD/Melanie 
Moser, 2002, ID# 3379. 
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Infections with Brugia spp. and W. bancrofti can result in lymphedema pathology, termed 
elephantiasis, with a deformation of the lower extremities caused by adult filaria-induced dilatation 
of the lymphatics by e.g. matrix metalloproteinases (MMP) and disordered lymph fluency 
(Bennuru and Nutman, 2009). The majority of filarial nematodes, including W. bancrofti or Brugia 
spp. contain endosymbiotic Wolbachia spp. bacteria that promote inflammatory responses and 
thus pathogenesis in filarial nematode diseases (Nutman, 2013; Pfarr et al., 2009; Taylor et al., 
2000). The filaria can also migrate to the lymphatics in the genitals of male patients resulting in 
hydrocele, the testicular disfiguration of the male genital tract. The life cycles of lymphatic filariasis 
and onchocerciasis are similar and infections often occur during childhood leading to severe 
disability of the adult patients. Consequently, infected patients often cause socio-economic 
problems in the endemic countries and are excluded from their society. 
 
The life cycle of Onchocerca volvulus (Onchocerciasis) 
In onchocerciasis infectious L3 larvae of Onchocerca volvulus are transmitted by blood-feeding 
blackflies (Simulium spp.). In contrast to LF, in O. volvulus infection the transmitted L3 larvae molt 
into adults in subcutaneous tissues leading to nodules, termed onchocercoma, that contain the 
adult filariae. Fertile female worms can produce microfilariae for approximately nine to fourteen 
years (Schulz-Key, 1990; WHO, 1995). Remarkably, chronic O. volvulus infections manifest 
clinically in dermatitis and chronic hyperreactive onchodermatitis (leopard-skin; sowda). The 
released microfilariae migrate to the sub-dermal layer of the host skin. During the next blood meal, 
the ingested microfilariae penetrate the midgut of the blackflies and migrate to the thoracic 
muscles and develop from first-stage larvae to L3 larvae. The pathology of Onchocerciasis is 
linked to the microfilarial stage. If microfilariae migrate from the nodules to the eye and die, a local 
inflammation occurs that can gradually lead to visual impairment and finally blindness driven by 
the disposal of Wolbachia spp. bacteria (Pearlman, 2003). As the transmitting Simulium flies 
require rivers for their development, onchocerciasis is always located close to rivers in endemic 
regions and is therefore termed as river blindness.  
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LF and onchocerciasis are classified by the WHO as neglected tropical diseases (NTDs). Beside 
LF and onchocerciasis, the NTDs also comprise worm infections like soil-transmitted 
helminthiasis caused by roundworms (Ascaris lumbricoides), whipworms (Trichuris trichiura), 
hookworm infections (Necator americanus and Ancylostoma duodenale), foodborne trematode 
infections (Clonorchis sinensis, Fasciola hepatica and Fasciola gigantica), schistosomiasis 
(Schistosoma spp.), and echinococcosis caused by tapeworms (Echinococcus granulosus and 
E. multilocularis). Non-helminth-based diseases of NTDs include human African trypanosomiasis 
and Chagas disease (Trypanosoma spp.) and viral infections like dengue haemorrhagic fever and 
chikungunya infection. Several programs have been implemented to eradicate lymphatic filariasis 
and onchocerciasis by preventive chemotherapy through mass drug administration (MDA). 
Moreover, the WHO initiated the elimination of the distribution of lymphatic filariasis by the year 
2020 (Ichimori et al., 2014).  
Therefore, the Global Programme to Eliminate Lymphatic Filariasis (GPELF) has been started in 
2000 to eliminate lymphatic filariasis in all 80 worldwide endemic countries (Ottesen, 2000). Up 
until the year 2014 the GPELF has delivered 5.6 billion treatments to over 763 million people 
(Turner et al., 2016). Because of an overlap of endemic areas for filarial diseases the annual or 
bi-annual MDA treatment options had to be adapted to prevent potential life threatening severe 
adverse events. Since disseminations of Loa loa and O. volvulus are limited to Africa, the MDA 
was conducted to diethylcarbamazine citrate (DEC) + albendazole (ALB) in endemic areas 
outside of Africa (de Kraker et al., 2006). Because of co-endemicity of lymphatic filariasis and 
onchocerciasis the MDA of ivermectin (IVM) + ALB was performed in Africa. Accordingly, severe 
adverse events had to be prevented in co-endemic areas for loasis (encephalitis promoted by 
treatment with DEC as well as IVM) and onchocerciasis (mazzotti reaction and blindness 
promoted by treatment with DEC).  
Because lymphatic filariasis and onchocerciasis are vector-transmitted diseases, vector-control 
programs were additionally started (Bockarie et al., 2009; Hougard et al., 2001).  
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Accordingly, with the aid of the African Programme for Onchocerciasis Control (APOC), the 
Onchocerciasis Elimination Program for the Americas (OEPA) and the Onchocerciasis Control 
Programme in West Africa (OCP), the distribution of onchocerciasis in South America is largely 
eliminated (CDC, 2013). Initial successes were achieved in Africa shown by epidemiological 
evaluations (2008-2014) initiated by APOC. In 32 affected areas (25.4 million people) 
onchocerciasis has almost been eradicated by the annual ivermectin mass drug treatment (MDA) 
(Tekle et al., 2016). Interestingly, the treatment in 18 areas (17.4 million people) depict more years 
of treatment but in eight areas (10.4 million people) the treatment was in this period unsuccessful.  
Furthermore, chemotherapy against LF and onchocerciasis targeting endosymbiotic Wolbachia 
is possible. The most common Wolbachia spp. are Wolbachia pipientis, W. melophagi and W. 
persica and are described for insects (Arthropoda), spiders (Chelicerata) and most human 
pathogenic filarial nematodes except e.g. Loa loa (McGarry et al., 2003). Furthermore, Wolbachia 
endosymbionts are not confirmed for all Mansonella spp. (Gehringer et al., 2014; Grobusch et al., 
2003). Interestingly, Wolbachia spp. are transferred to the ovule of the next generation of the host 
organism via vertical transmission and are essential for filarial fertility and survival (Hoerauf, 
2008). As a consequence, depletion of Wolbachia spp. with antibiotics leads to sterile filariae and 
thus prevent transmission of filarial infection. Furthermore, anti-Wolbachia therapy is the only safe 
treatment that has a macrofilaricidal effect, i.e. kills the adult worms (Hoerauf et al., 2008; Hoerauf 
et al., 2000). Notably, Wolbachia spp. constitute ligands e.g. for Toll-like-receptor (TLR) 2 and 4 
as well as the nucleotide-binding oligomerization domain containing 1 and 2 (NOD) (Ajendra et 
al., 2016b; Brattig et al., 2004; Pearlman, 2003). Thus, Wolbachia spp. trigger activation and 
recruitment of host immune cells expressing these receptors, e.g. neutrophils, eosinophils and 
macrophages (Tamarozzi et al., 2011).  
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1.1.2 Immunopathogenesis of human lymphatic filariasis and onchocerciasis 
 
The interplay between filariae and the human host may induce immunopathology. The severity of 
the pathology is dependent on the ratio between pro-inflammatory and anti-inflammatory 
responses, the level of immunomodulation induced by the parasite and the genetic background 
of the host. In O. volvulus infection, suppressive CD4+ T cells producing interleukin (IL)-10/ 
transforming growth factor (TGF) and expressing elevated levels of cytotoxic T-lymphocyte-
associated Protein (CTLA)-4, known as cluster of differentiation (CD)152, expand and are 
associated with reduced pathology (Doetze et al., 2000; Satoguina et al., 2002). In 
onchocercomas of hyporeactive patients altered TGF-1 expression of T cells, platelets, 
plasma/B cells, macrophages and increased levels of IgG4 are mediating immunosuppression 
and inducing microfilariae tolerance (Adjobimey and Hoerauf, 2010; Korten et al., 2009; Korten 
et al., 2010). In contrast, in hyperreactive human onchocerciasis reduced levels of TGF-1 and 
IgG4, increased HLA-DR expression and elevated type 2 immune responses including increased 
numbers of eosinophil granulocytes result in severe dermatitis and lymphadenitis, but promote 
defense against parasites (Korten et al., 2011).  
Moreover, O. volvulus infected patients with the genetic IL-13 variant Arg110Gln have increased 
levels of IL-13, which is associated with a higher risk to develop hyperreactive onchocerciasis 
(Hoerauf et al., 2002). In hyperreactive patients type 2 immune responses and Th17 immune 
responses are increased, whereas regulatory T cells are reduced (Katawa et al., 2015). 
Furthermore, in lymphatic filariasis the TGF-1 Leu10Pro polymorphism leads to reduced levels 
of TGF-1 and is associated with a lack of microfilariae in the blood of the infected patients 
(Debrah et al., 2011). Interestingly, polymorphisms in plasma Vascular Endothelial Growth 
Factor-A (VEGF-A) are associated with an increased risk of developing hydrocele (Debrah et al., 
2007; Pfarr et al., 2009). Moreover, effector CD4+ and CD8+ T cells are discussed to trigger the 
development of the pathogenesis in lymphatic filariasis and onchocerciasis by supporting pro-
inflammatory Th1, Th9 and Th17 type immune responses (Anuradha et al., 2014; Babu et al., 
2009a; Babu and Nutman, 2014).  
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Human monocytes mediate an essential function in the immunopathogenesis during filarial 
infection. An alternative activation of those monocytes with an increased expression of arginase-
1 (ARG1) and mannose receptor C type 1 (MRC1) was shown in asymptomatic B. malayi infected 
individuals (Babu et al., 2009b). Monocytes of asymptomatically infected people develop a 
regulatory and anti-inflammatory phenotype with increased anti-inflammatory TGF and IL-10 
expression and decreased pro-inflammatory IL-12 and IL-18 expression, as was described after 
re-stimulation with B. malayi crude extract (BmA) (Babu et al., 2009b). Furthermore, the lysate of 
B. malayi microfilariae can modulate the cytokine and chemokine production of naïve monocytes 
and suppress adaptive and innate immune responses by the expression of regulatory PD-L1 
(CD274) and IL-10 as was shown by W. bancrofti asymptomatically infected patients (O'Regan 
et al., 2014). Subsequently, IL-10 induces microRNA-187 that negatively regulates tumor necrosis 
factor (TNF), IL-6, and IL-12p40 production in TLR4-stimulated monocytes (Rossato et al., 2012). 
Live B. malayi mf induce the expression of PD-L2 (CD273) and the downregulation of TLR3 
(detects double-stranded RNA, poly I: C), TLR5 (detects profilin and bacterial flagellin), and TLR7 
(detects among others single-stranded RNA) expression (Semnani et al., 2011). Accordingly, the 
chemokines CCL15, CCL17, CCL18, CCL22 are upregulated and involved in immune cell 
trafficking. Live B. malayi mf induce autophagy in human dendritic cells by inhibiting the mTOR 
pathway and thus IL-12 and IL-10 production and the capacity to activate CD4+ T cells 
(Narasimhan et al., 2016; Semnani et al., 2003). Thus, monocytes play a pivotal role during filarial 
infection due to their capacity to change their phenotype and to develop into specialized 
phagocytes and antigen presenting macrophages or dendritic cells (Guilliams et al., 2014; 
Semnani, 2013). Furthermore, monocytes produce cytokines and chemokines but also matrix 
metalloproteinases (MMPs) that contribute to the development of lymphangiogenesis and thus 
the pathology of a filarial infection. 
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1.1.3 Immunomodulation by helminths and helminth-derived molecules 
 
Helminths modulate cellular functions for their long-time survival and reproduction. Dependent on 
the host’s immunity, the clinical picture varies during infection. Filariae and filariae-derived 
products possess a high potential to modify innate and adaptive immune responses of the host 
(Allen and Maizels, 2011). Based on the co-evolution of parasites and their host, the hygiene 
hypothesis was postulated, which explains the increased rates of allergy and autoimmune 
diseases in developed countries by an improved hygiene and the resulting loss of infections 
(Cooke, 2009; de Ruiter et al., 2017; Maizels, 2016). Helminth–derived products and infections 
can improve e.g. experimental autoimmune type 1 diabetes and diet-induced glucose intolerance 
(Ajendra et al., 2016a; Berbudi et al., 2016b; Hübner et al., 2012b; Hübner et al., 2009a). Hence, 
immunomodulation by helminth infections plays an important role in a balanced immune system 
(Helmby, 2015).  
Helminth infections induce a type 2 immunity with increased systemic levels of Th2 cytokines IL-
4, IL-5, IL-13, and B cell derived immunoglobulins IgE, IgG1 in mice and IgG4 in humans (Maizels 
et al., 2004). Accordingly, Th2 cytokine-producing CD4+ T cells expand during helminth 
infections. CTLA-4 expression is altered in regulatory B and T cells that release anti-inflammatory 
IL-10 and TGF and are supporting regulatory, anti-inflammatory immune responses during 
infection. During chronic filarial infection alternatively activated macrophages (AAM) that express 
resistin-like molecule alpha (RELM but also basophils, mast cells and neutrophil granulocytes, 
are induced. Eosinophil granulocytes are a hallmark of helminth infections (Behm and Ovington, 
2000; Huang and Appleton, 2016). Type 2 innate lymphoid cells (ILC2) are also characteristically 
increased by filarial infections promoting Th2 responses (Boyd et al., 2015). IL-13+ neutrophil 
granulocytes (N2) were characterized in secondary Nippostrongylus brasiliensis infections (Chen 
et al., 2014). Since lymphatic filariasis patients have an increased risk to acquire HIV (human 
immunodeficiency virus)-infections (Kroidl et al., 2016), immunomodulation by helminth may have 
a chitinase-like 3 (YM1)-dependent promoting effect on the impairment of antiviral immunity 
(Buerfent et al., 2015; Osborne et al., 2014).  
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Filarial nematodes release various immunomodulatory components during the different stages of 
infection. Excretory/secretory proteins can interfere with host cells and affect antigen processing 
and presentation to reduce inflammatory pathogenic immune responses. Consequently, the 
phosphorylcholin containing glycoprotein excretory/secretory (ES)-62 and its analogs derived 
from the rodent filarial nematode Acanthocheilonema vitae reduce the pathogenesis in different 
inflammatory-driven diseases like allergies (Rzepecka et al., 2014), rheumatoid arthritis (Pineda 
et al., 2012) and atherosclerosis (Aprahamian et al., 2015).  
ES-62 interacts with the pattern recognition receptor (PRR) TLR 4 (CD284) on macrophages and 
dendritic cells by targeting the myeloid differentiation factor 88 (MyD88) (Goodridge et al., 2005; 
Goodridge et al., 2007). ES-62 treatment also protects against kidney damage in an MRL/lpr 
mouse model of systemic lupus erythematosus (SLE) (Rodgers et al., 2015a). Besides 
macrophages and dendritic cells, ES-62 modifies B cells, mast cells and T cells (Al-Riyami and 
Harnett, 2012). In addition, filarial-derived Brugia malayi adult worm extracts and the 
Litomosoides sigmodontis crude extract were shown to induce macrophage tolerance in a TLR 
dependent manner that counter-regulates inflammatory responses (Gondorf et al., 2015; Turner 
et al., 2006). E/S products from the intestinal helminth parasites A. viteae and Heligmosomoides 
polygyrus induce Th2 immune responses, IL-10 producing regulatory T cells and inhibit T cell 
proliferation and macrophage nitric oxide production (Hewitson et al., 2009). However, the 
protection of experimental H. polygyrus infection against colitis-induced intestinal inflammation is 
due to suppression of the mucosal IL-17 production, but independent of IL-10 (Elliott et al. 2008; 
Elliott et al. 2004).  
Furthermore, filarial nematodes produce cysteine protease inhibitors termed cystatins (Klotz et 
al., 2011a). Cystatins are essential pathogenicity factors and interfere with antigen processing 
and presentation that leads inter alia to a reduction of T cell responses (Hartmann and Lucius, 
2003). In humans, the cystatin homolog derived from B. malayi (Bm-CPI-2) inhibits multiple host 
cysteine protease activities in the endosomes/lysosomes and reduces MHC class II -restricted 
antigen processing (Manoury et al., 2001). Cystatin derived from A. viteae (AvCystatin) or O. 
volvulus (Onchocystatin) modulate macrophages and induce both pro- and anti-inflammatory 
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cytokines like TNF and IL-10. (Klotz et al., 2011b; Schonemeyer et al., 2001). AvCystatin induces 
regulatory macrophages and modulates via dual specificity phosphatase (DUSP) 1 and 2, thus 
inducing IL-10 expression. Interferon (IFN)  cultured macrophages respond to cystatins with an 
up-regulation of nitric oxides (Hartmann et al., 2002; Verdot et al., 1996). Consequently, 
recombinant cystatin (rBmCys) and recombinant abundant larval transcript 2 (rBmALT2) of B. 
malayi are effective therapeutics in the experimental model of dextran sulfate sodium (DSS)-
induced colitis (Khatri et al., 2015a; Khatri et al., 2015b; Kumar et al., 2016). RBmALT2 is an 
effective anti-inflammatory therapeutic against streptozotocin (STZ)-induced type 1 diabetes in 
mice (Reddy et al., 2017).  
Correspondingly, abundant larval transcripts (ALT) are highly conserved filaria E/S products and 
are found in A. viteae (Pogonka et al., 1999), W. bancrofti and O. volvulus (Madhumathi et al., 
2010; Sakthidevi et al., 2014). Immunomodulatory ALT are the most abundant E/S products from 
infectious L. sigmodontis third stage larvae (Allen et al., 2000; Hewitson et al., 2009). Soluble 
antigens of Schistosoma spp. are also described as immunomodulators. Soluble schistosomal 
egg antigens (SEA) bind to Dectin-2/FcR (Fc receptor  chain) complex and modify host immune 
responses by NLRP3 (NLR family, pyrin domain containing 3) inflammasome activation and IL-
1β production (Ritter et al., 2010) by suppressing TLR-dependent responses (Kane et al., 2004; 
Kane et al., 2008). Subsequently, Omega (Ω)-1, a glycoprotein and single component secreted 
by S. mansoni eggs, drives Th2 responses in human dendritic cells (Everts et al., 2009; 
Steinfelder et al., 2009).  
The administration of Heligmosomoides polygyrus derived exosomes suppresses allergen-
induced Type 2 innate responses and eosinophilia by suppressing DUSP1 and IL-33R genes 
(Buck et al., 2014). Similarly, filarial nematodes secrete extracellular vesicles like exosomes with 
a size of 30-100nm that contain small RNAs (microRNA and Y RNAs) and nematode Argonaute 
proteins, which are internalized by host cells and modulate innate immunity (Marcilla et al., 2014; 
Marcilla et al., 2012). Exosome-like vesicles secreted by infectious L3 larvae were described for 
the human pathogenic filaria B. malayi (Zamanian et al., 2015) and the inhibition of inflammatory 
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responses and the induction of regulatory immune cells by helminth-derived exosomes containing 
miRNA is discussed for allergy and autoimmune diseases (Siles-Lucas et al., 2015). In contrast, 
exosome-like vesicles derived by Schistosoma japonicum adult worms (blood fluke) mediate M1-
type immune responses of macrophages in vitro (Wang et al., 2015).  
 
1.1.4 Murine Litomosoides sigmodontis infection as model for human filarial infections 
 
Since Litomosoides sigmodontis establishes patent infections (occurrence of microfilaremia) in 
rodents and induces immune responses that are similar to human filarial nematode infections, 
experimental L. sigmodontis infection is an accepted model for human filariasis (Allen et al., 2008; 
Hoffmann et al., 2000). L. sigmodontis is transmitted by the tropical rat mite Ornithonyssus bacoti 
to the natural rodent host Sigmodon hispidus (cotton rat) in different tropical and subtropical parts 
of America. L. sigmodontis can also infect different strains of (semi)-susceptible mice like C57BL/6 
(only prepatent infection) and BALB/c (patent infection) laboratory inbred mice. Similar to human 
pathogenic filarial nematodes, L. sigmodontis L3 larvae are the infectious stage for the rodent 
host (Fig. 3) (Hübner et al., 2009b). Two to six days post infection (dpi) the transmitted L3 larvae 
reach the thoracic cavity and molt to juvenile L4 worms. The L4 worms become adult around 30 
dpi and start to release microfilariae (L1 worms) that are transmitted to the intermediate host 
during the blood meal 50 days after the infection. In O. bacoti, the mf mature via L2 to L3 infective-
stage larvae that are transmitted to the rodent host during the next blood meal. 
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Figure 3: Life cycle of the rodent filaria nematode Litomosoides sigmodontis. After L3 infective-stage larvae transmission during 
the blood meal of the tropical rat mite Ornithonyssus bacoti, the larvae become adult in the pleural cavity and produce 
microfilariae (L1 larvae) that are transmitted with the next blood meal. The microfilariae develop into L3 larvae within the rodent 
vector and infect the host during the next blood meal (Hübner et al., 2009b). 
 
1.2 Helminth-mediated protection against LPS-driven immune diseases 
 
The capability of helminth and helminth antigens to modulate host immune responses revealed 
protective effects on inflammatory disorders (Soares and Araújo, 2008). The induction of a 
regulatory and anti-inflammatory milieu suppresses and counter-balances exacerbated pro-
inflammatory immune responses caused by systemic bacterial infections or LPS-induced 
endotoxemia (Hübner et al., 2013). Sepsis is a complex dysregulation of the immune system 
caused by the coincidence of an infection by microorganisms like bacteria or fungi inducing a 
systemic (pro-)inflammatory response syndrome (SIRS) that leads to fever (≥38°C) or 
hypothermia (≤36°C), leukocytosis (≥12.000/mm³) and/or an increased heart rate (≥90/min) (S2k 
guidelines) (Reinhart et al., 2010).  
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The SIRS phase is followed by a compensatory anti-inflammatory response syndrome (CARS) 
dominated by immunosuppression and increased risk of secondary infections (Bone et al., 1992). 
Severe sepsis and septical shock can lead to multiple organ failure, hypoxia (≤75mmHg) and cell 
apoptosis (Buras et al., 2005). The succeeded alternation of SIRS to CARS is termed mixed 
antagonistic response syndrome (MARS) (Weigand et al., 2003). Due to a mortality of 50% in 
patients with septic shocks (Morrell et al., 2009) and mortality rates of severe septic patients in 
intensive care units from 40 to 66%, sepsis is one of the leading causes of death worldwide (Beale 
et al., 2009; Martin et al., 2003).  
 
1.2.1 Immunopathogenesis of bacterial-induced inflammation 
 
Microbial invaders are primarily detected by innate immune cells like macrophages and dendritic 
cells by pattern recognition receptors, e.g. Toll-like-receptor 2 and 4 (Akira et al., 2006). After the 
detection of the pathogen-associated molecular pattern (PAMP) e.g. the TLR2 ligand lipoprotein 
(LP) from gram- positive or the TLR4 ligand lipopolysaccharide (LPS) of gram- negative bacteria, 
the activation results in an excessive production of pro-inflammatory immune responses, initiating 
the SIRS phase (Danner et al., 1991; Oliveira-Nascimento et al., 2012). The binding of LPS to the 
TLR4/MD2 complex activates both the signal cascades of the adapter molecule myeloid 
differentiation primary response gene (MyD)88 resulting in pro-inflammatory Th1 cytokines TNF, 
IL-6 and IL-12 release and the adapter molecule TRIF (interferon-inducible genes like IFN and 
IFN) signaling (Van Amersfoort et al., 2003). Additionally, the LPS binding initiates the cleavage 
and thus activation of cytosolic IL-1 (Martinon et al., 2009). The activation of macrophages is 
accompanied by the upregulation of the major histocompatibility complex (MHC) class II surface 
receptor, CD80 and CD86 to induce the activation and the production of Th1 cytokines by CD4+ 
T cells that promote cytotoxic CD8+ T cells for pathogen killing in humans and mice (Hotchkiss 
and Opal, 2010). The exacerbated production of pro-inflammatory mediators can result in an 
excessive activation and recruitment of neutrophil granulocytes, which improve bacterial 
clearance but also increase tissue damage by the release of proteases (Cohen, 2002).  
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The exacerbated inflammation is counter-balanced by the induced homoeostasis during sepsis 
progression. Subsequently, the CARS phase is accompanied by T cell anergy (Venet et al., 2009) 
and characteristically increased numbers of IL-10 and TGF producing regulatory and 
suppressive T cells and increased CTLA-4 expression by T cells (Hotchkiss and Opal, 2010; 
Venet et al., 2008). During the SIRS phase the expression of type I interferons by splenic 
macrophages results in immunosuppression and thus impaired adaptive immune responses 
against secondary infections after severe sepsis (immune paralysis) (Schwandt et al., 2012).  
 
1.2.2 Helminth-mediated immunomodulation against bacterial-induced sepsis 
 
During the last decades several studies have investigated whether the administration of 
regulatory mediators IL-10 (Howard et al., 1993; Schulte et al., 2013), IL-7 (Unsinger et al., 2012; 
Unsinger et al., 2010), IL-15 (Inoue et al., 2010), neutralizing antibodies against pro-inflammatory 
IL-1 (Fisher et al., 1996) and TNF (TNF receptor bound to Fc portion of IgG1 (TNFR:Fc)) (Fisher 
et al., 1996), the blocking of the TLR4/MD2 complex (eritoran tetrasodium (E5564)) (Kalil et al., 
2011; Paramo et al., 2015; Roger et al., 2009) or TLR2 antagonists improve sepsis survival (Meng 
et al., 2004). Although several experimental results revealed a beneficial effect by impairing the 
uncontrolled inflammation, those results were not confirmed in human clinical trials and are 
probably due to the diverse clinical picture of sepsis, the diversity of microorganisms and the 
necessity to improve both the SIRS and CARS phase (Riedemann et al., 2003a). 
 
Similar to experimental helminth infections and helminth product administrations that revealed an 
immunomodulatory protective effect on autoimmune diseases like diabetes (Berbudi et al., 
2016a), initial experiments depicted a protective effect of helminths to reduce exacerbated pro-
inflammatory immune responses without impairing bacterial control. The helminth defense 
molecule of Fasciola hepatica (FhHDM-1) directly binds to LPS and reduces its interaction with 
LPS-binding protein on the surface of macrophages, thus protecting mice against LPS-induced 
endotoxemia (Robinson et al., 2011).  
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Similarly, the tegument antigen of F. hepatica suppresses serum IL-12p70 and IFN levels by 
impairing dendritic cell maturation and function (Hamilton et al., 2009). The chito-oligosaccharide 
chitohexaose blocks LPS-induced endotoxemia and pro-inflammatory TNF, IL-1 and IL-6 
production via TLR4 receptor interaction and induces alternative Arginase-1 and IL-10 expression 
in murine macrophages and human monocytes (Panda et al., 2012). Accordingly, an infection 
with the murine intestinal helminth Nippostrongylus brasiliensis improves the survival of Klebsiella 
pneumoniae-induced peritonitis that correlates with a reduced peritoneal bacterial load 
(Sutherland et al., 2011). 
 
 
Figure 4: Helminth-mediated protection against bacterial induced sepsis. Helminth infection and the release of mediators like 
endosymbiotic Wolbachia spec. or components like Chitohexaose interfere with pathogen-recognition receptors like TLR2/4. 
Induced regulatory T cells, T helper 2 cells, innate lymphoid cells (ILCs) and alternatively activated macrophages (AAM) may reduce 
excessive inflammation amongst others by the release of anti-inflammatory mediators IL-10 and TGFβ and by re-programming 
macrophages. The immunomodulation by helminths improves phagocytosis, bacterial control and sepsis pathology (Hübner et al., 
2013). 
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Chronic L. sigmodontis infection reduces pro-inflammatory immune responses and ameliorates 
Escherichia coli-induced hypothermia (Gondorf et al., 2015). The protective effect is Wolbachia 
spp. and TLR2-dependent and associated with an increased phagocytic activity and 
downregulation of genes involved in TLR signaling that increases sepsis survival (Fig. 4). My own 
work demonstrated hereby that the E. coli-induced immune paralysis during the 
immunosuppressive CARS phase is not exacerbated in chronic L. sigmodontis infected mice 
(Buerfent et al., 2015). Correspondingly, Mycobacterium tuberculosis pathology and control is not 
worsened by chronic filarial infection (Hübner et al., 2012a). Whereas the implantation of L. 
sigmodontis female adult worms from prepatent infections protect mice, microfilariae injection 
exacerbates LPS-induced endotoxemia through the induction of increased pro-inflammatory 
responses (Hübner et al., 2008).  
 
Eosinophil granulocytes are a hallmark of parasitic helminth infections and provide anti-parasitic 
properties (Huang and Appleton, 2016). Principally, eosinophils are required for the long-term 
maintenance of plasma cells in the bone marrow by their IL-6 and APRIL (a proliferation-inducing 
ligand) release (Chu et al., 2014; Chu et al., 2011), whereas the role of eosinophils on bacterial 
sepsis is controversially discussed. Eosinophils have the capacity to support the clearance of 
bacterial infections. IL-5, the main inducer of eosinophils and produced by eosinophils 
themselves, was shown to be protective in sublethal cecal ligation and puncture (CLP) sepsis in 
an eosinophil-independent manner (Linch et al., 2012). Several publications indicate anti-bacterial 
properties of eosinophils in vitro and in vivo (Linch et al., 2009; Pulido et al., 2012). Accordingly, 
LPS triggers eosinophil recruitment and accumulation via C-C chemokine receptor type (CCR) 3 
activation (Penido et al., 2001) and spontaneously released extracellular structures of eosinophil-
derived mitochondrial DNA and proteins reduce bacterial burden in vitro (Yousefi et al., 2008). 
Hence, the eosinophil count is discussed to be a diagnostic marker for sepsis survival in humans 
(Merino et al., 2012; Terradas et al., 2012).  
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1.3 Objectives of the thesis 
 
Chronic helminth infections modulate immune responses, thus protecting against bacterial-
induced systemic inflammation. The immunomodulatory capacity of helminth products and 
helminth infections were mainly focused on the detection of immunomodulatory mediators 
(McSorley et al., 2013) and their capacity to improve diseases that are due to dysregulated 
immune responses (El-Malky et al., 2011; Gondorf et al., 2015).  
Part A - Impact of eosinophil granulocytes on E. coli-induced sepsis 
The first aim of my thesis was to investigate the impact of the hallmark cell population of parasitic 
infections (Rosenberg et al., 2013), eosinophil granulocytes, on the development of an 
experimental E. coli-induced sepsis. Consequently, I investigated whether transfer of bone-
marrow derived eosinophils is protective against E. coli-induced sepsis and if the reduction of 
systemic inflammation during the SIRS phase is eosinophil-dependent. In this context, genome-
wide transcriptional profiling comparing eosinophils of L. sigmodontis-infected mice, naïve mice 
and eosinophils obtained during sepsis in L. sigmodontis-infected and uninfected mice was 
performed to identify transcriptional changes in eosinophils that may reveal diverse functions in 
different immunological settings. 
Part B - Genome-wide transcriptome analysis of human monocytes stimulated with helminth 
extracts and LPS reveal a link to IL-17 associated diseases 
Since helminth extracts of the human pathogenic filaria Brugia malayi (BmA) are known to 
modulate inflammatory responses, the second aim of this thesis was to perform a genome-wide 
transcriptional profiling of BmA crude extract primed and LPS re-stimulated monocytes of human 
male non-endemic donors. Based on differentially expressed genes we performed a 
transcriptome-wide association analysis of relevant pathways by IPA® analysis to reveal 
immunomodulation by filarial extracts and their potential impact on autoimmune diseases and the 
development of filarial pathology.   
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Material & Methods 
 
2.1 Murine studies 
 
2.1.1 Ethics statement and mice 
 
All mice were housed in the animal facility of the Institute for Medical Microbiology, Immunology 
and Parasitology of the University Hospital Bonn, Germany, with access to food and water ad 
libitum. All performed experimental procedures were approved by the Landesamt für Natur, 
Umwelt und Verbraucherschutz, Cologne, Germany and performed according to the European 
Union animal welfare guidelines. Female homozygous ΔdblGATA-1 gene deficient mice were 
purchased from The Jackson Laboratory, Bar Harbor, USA. The age-matched female BALB/cJ 
wild type (WT) controls were obtained from Janvier Labs, Le Genest-Saint-Isle, France.  
2.1.2 Chronic filarial infection model – Litomosoides sigmodontis 
 
As previously described by Ajendra et al. (Ajendra et al., 2014), healthy 6 to 8 week old mice were 
naturally infected with the rodent filarial nematode Litomosoides sigmodontis (L. s.) via the tropical 
rat mite Ornithonyssus bacoti. For maintenance of the life cycle, L. sigmodontis infected cotton 
rats (Sigmodon hispidus) were exposed to mites. Ninety days post infection (p.i.) the experiments 
were performed. The chronic filarial infection was confirmed by the identification of adult worms 
within the thoracic cavity and the presence of microfilariae in the peripheral blood (20µl blood + 
1mL red blood lysis buffer (eBioscience/Affymetrix, Santa Clara, USA)) following necropsy. 
2.1.3 Bacterial sepsis model 
 
Chronic L. sigmodontis-infected mice and controls were intraperitoneally (i.p.) challenged with 
1x108-1x109 colony forming units [cfu] of gram-negative Escherichia coli K12 (ATCC 25922) in a 
200µL sterile lysogeny broth medium and monitored for six hours. Mice developing severe 
septical symptoms like hematuria and body temperature <27°C were prematurely euthanized 
according to humane endpoint criteria by an overdose of isoflurane (AbbVie Deutschland GmbH 
& Co. KG, Wiesbaden, Germany). The body temperature decrease was measured hourly by 
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infrared measurement as previously described (Gondorf et al., 2015). The mice were euthanized 
after six hours and the peritoneal and pleura lavage was performed by injecting 1 and 4mL (total 
5mL) of cold PBS. The first mL of the peritoneal lavage was used to determine the bacteria 
concentration (plated as serial dilutions on Luria–Bertani (LB) agar plates and incubated overnight 
at 37°C) as well as the cytokine and chemokine concentrations after centrifugation at 300 g for 
10 min (stored at -20°C). The combined cell pellet was used to determine peritoneal cell 
populations and numbers. Cells were counted using the CASY TT (Roche, Pensberg, Germany). 
The systemic cytokine and chemokine concentration was determined in the peripheral blood after 
centrifugation at 1000 g for 10 min and storage at -20°C.  
2.1.4 Eosinophil culture  
 
Eosinophil granulocytes were generated using an optimized in vitro differentiation protocol from 
the bone marrow of BALB/cJ mice (Dyer et al., 2008). In brief, the bone marrow was cultured (at 
37°C, 5% CO2 and 95% humidity) with 100 ng/mL recombinant murine SCF and FLT3-L for 4 
days, followed by 20ng/mL recombinant murine IL-5 for 8 days (all three from Peprotech, St. 
Louis, USA) in an RPMI 1640 advanced medium containing 20% fetal calf serum, 25 mM HEPES, 
1X GlutaMAX (all from Gibco Technologies / Thermo Fisher Scientific, Waltham, USA) and 100 
U/ml penicillin + 10 µg/mL streptomycin (both from PAA / GE Healthcare, Pasching, Austria) in 
Advanced TC™ flasks with filter caps (Greiner Bio-One, Kremsmünster, Austria). The purity was 
checked by flow cytometry and always exceeded 95% SSChiSiglecF+ eosinophil granulocytes. 
2.1.5 In vitro experiments of bone-marrow-derived eosinophil granulocytes 
 
The in vitro experiments were performed using the previously mentioned sterile medium. The 
bone-marrow-derived eosinophil granulocytes (bmEos) were incubated at 37°C and 5% CO2 for 
24 hours with CCL11 or CCL24, followed by a 24h stimulation with LPS E. coli ultrapure [300 
ng/mL], Pam3CSK4 [100 ng/mL] (both Invivogen, San Diego, USA) and L. sigmodontis crude 
adult worm extract (LsAg) [25 µg/mL]. Single stimulated cells served as controls. The supernatant 
of the in vitro experiments was stored at -20°C until measurement by ELISA. The in vitro bacteria 
killing assays were done in medium lacking antibiotics. The bacteria were suspended in PBS 
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(1x107 bacteria in 10 µL) and co-incubated at 37°C for 3h (Yousefi et al., 2008). The suspension 
was plated on LB agar plates and after incubation for 18 hours at 37°C, the number of CFUs was 
determined optically. 
2.1.6 Flow cytometry and immunoassays of murine experiments 
 
The cells of the in vivo and in vitro experiments were first blocked with PBS containing 1% bovine 
serum albumin and 0.1% rat immunoglobulin (Sigma-Aldrich, St. Louis, USA) for 30 min at 4°C. 
After a washing step with cold PBS at 300 g for 10 min, cells were stained for 30min with 
combinations of anti-mouse antibodies SiglecF PE or AL647 (Clone: E50-2440) (both BD 
Pharmingen), F4/80 APC or PerCP-Cy5.5 (Clone: BM8), Ly6G PE (Clone: 1A8), Ly6C PerCP-
Cy5.5 or APC-Cy7 (Clone HK1.4) (all BioLegend) and CD11b FITC or PE-Cy7 (Clone: M1/7; 
eBioscience). For intracellular staining the cells were first incubated with fixation and 
permeabilization buffer overnight (eBioscience). Afterwards, the cells were stained in two steps 
in permeabilization buffer with rabbit anti-murine RELM (Peprotech), followed by donkey anti-
rabbit IgG Alexa Fluor 647 (Clone: Poly4064) (BioLegend) or goat anti-rabbit IgG (H+L) Alexa 
Fluor 488 (Thermo Fisher Scientific). For activation analysis, cells were stained with CD69 PE 
and CD86 PE (eBioscience, San Diego, USA). The cells were analyzed on a BD Canto flow 
cytometer combined with Diva 6.0 software (BD Bioscience, San Jose, USA) and the data was 
subsequently analyzed by FlowJo v10 software (FLOWJO LLC, Ashland, USA). 
The cytokine concentrations of interleukin-4, interleukin-6, CXCL1 (KC) and CCL5 (RANTES) as 
well as tumor necrosis factor , interferon , interleukin-10 and CXCL2 (MIP-2) were determined 
from cell culture supernatants and plasma by Enzyme Linked Immunosorbent Assay (ELISA) 
(eBioscience and R&D) according to kit protocols on a SpectraMAX 190 with SoftMAX Pro 6.5 
software (Molecular Devices, Sunnyvale, USA).  
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2.1.7 RNA sequencing and transcriptome profiling of sorted eosinophil granulocytes 
 
Viable FSChiSSChiHoechst33258negCD11b+F4/80+SiglecF+ eosinophil granulocytes (Fig. 5) were 
sorted directly after peritoneal and pleural lavage with 10 ml RPMI 1640 containing 10% FCS of 
L. sigmodontis infected and non-infected BALB/c mice six hours after E. coli or PBS injection (BD 
FACSAria™ III, BD Biosciences). Additionally, eosinophils were sorted from the intestine of non-
infected mice (in collaboration with Prof. Dr. Christoph Wilhelm, University Hospital of Bonn). 
 
Figure 5: Representative gating-strategy of sorted murine eosinophils for subsequent RNA sequencing. 
In brief, the intestine and the Payer Patches were removed. Afterwards, the intestine was cut into 
small pieces and digested with Liberase TM (Roche, Basel, Switzerland) under continuous stirring 
for 30 min. Afterwards, the intestinal pieces and cell suspension were homogenized through a 70 
µm cell strainer, centrifuged for 8 min at 330 g at 4°C and passed through a 40 µm cell strainer. 
The single cell suspension was then blocked with a medium containing 3% FCS and 0.1% rat 
immunoglobulin for 30 min and stained with the same fluorescence-coupled antibodies that were 
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used as previously mentioned. The sorted cells were centrifuged at 300 g for 10 min, lysed in RLT 
Buffer Plus (QIAGEN, Venlo, Netherlands) and stored at -80°C until RNA preparation. 
Subsequently, total RNA was extracted using the RNeasy Plus Micro Kit from QIAGEN following 
the manufacturer`s instruction (QIAGEN). For quality control, RNA concentrations were measured 
using NanoDrop (PeqLab, Erlangen, Germany) and degradation via Qubit® RNA HS Assay Kit 
(Thermo Fisher Scientific, Waltham, USA). The RNA sequencing was performed using QuantSeq 
3' mRNA-Seq Library Prep Kit FWD for Illumina (Lexogen, Vienna, Austria) and HiSeq 2500 
(1x50bp, single-read, Rapid Modus; Illumina, San Diego, USA). Data analysis was performed 
using ShinyOmics and ShinyDGEA (Jan Gehlen, Human Genetics of University Hospital of Bonn, 
Germany), a browser based compilation of the packages Subread aligner 1.5.1 
(http://subread.sourceforge.net/), multiQC 0.8 (https://github.com/ewels/MultiQC) and limma 
3.30.11 (https://bioconductor.org/packages/ release/bioc/html/limma.html).  
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2.2 Human study 
 
2.2.1 Human study population 
 
The human study was approved by the ethics committee of the University of Bonn. 20 healthy 
male Caucasian volunteers of European origin at age of 18 to 35 years were recruited and 
peripheral blood samples were taken. The inclusion criteria were the following: at least three 
generations of grandparents in Central Europe, non-smoker, no acute or chronic infection, no 
surgery or vaccination four weeks prior to blood withdrawal and C-reactive protein (CRP) levels 
< 2.5 mg/dl. Female donors were excluded due to hormonal factors which could possibly have 
influenced transcriptional expression patterns. The patients gave their consent to the anonymous 
publication of the results. 
2.2.2 Monocyte isolation 
 
Peripheral blood mononuclear cells were purified using a Ficoll-Plaque density gradient from 
heparinized whole blood (Gölz et al., 2016a). Afterwards, CD14+ monocytes were isolated by 
using CD14-microbeads and the AutoMACS Pro Separator system according to the 
manufacturer`s instruction (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany). The cell purity 
of CD14+ cells was determined by flow cytometry (see section 2.2.4). After separation, the cells 
were re-suspended in RPMI 1640 media, supplemented with GlutaMAXTM, 10% heat-inactivated 
FCS (Gibco® Life Technologies, Waltham, USA), 100 U/ml penicillin, and 100 µg/ml streptomycin 
(both PAA Laboratories/GE Healthcare, Pasching, Austria).  
2.2.3 Monocyte stimulation 
 
The purified monocytes (> 95% purity) were cultured in 96-well round bottom wells at a density of 
500.000 cells/well in 100 µl for 2 h after separation. Afterwards, the cells were stimulated with 10 
µg/ml Brugia malayi adult worm crude extract (BmA) for 18 h and re-stimulated for an additional 
six hours with 200 ng/ml LPS Escherichia coli ultrapure (InvivoGen, San Diego, USA). All 
experiments were performed using one batch of BmA that was prepared according to the L. 
sigmodontis crude extract (Ziewer et al., 2012). BmA was tested for detectable endotoxin levels 
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by QCL-1000™ Endpoint Chromogenic LAL assay (Lonza, Basel, Switzerland). The cell viability 
of BmA stimulated monocytes was tested by the Colorimetric Cell Viability Kit III (XTT; PromoKine, 
Heidelberg, Germany). Unstimulated and BmA- or LPS-only stimulated monocytes served as 
controls. After stimulation the supernatants were collected and the cells were lysed in RLT Plus 
buffer (QIAGEN, Hilden, Germany) and stored at -80°C. In additional experiments, monocytes 
were stimulated (after a resting period of 2 h) for 18 h or 24 h with BmA followed by 24 h or 18 h 
of LPS stimulation (total 42 h), respectively. Additionally, a long-term treatment of 48 h, including 
a 24 h and 42 h priming with BmA followed by 24 h or 6 h of LPS re-stimulation, was performed. 
2.2.4 Flow cytometry and immunoassays of human monocyte experiments 
 
The overnight monocyte survival was checked microscopically by trypan blue staining and 
confirmed by Annexin V and propidium iodide analysis (eBioscience, San Diego, USA) via flow 
cytometry (Gölz et al., 2016a). For the analysis of monocyte activation, the cell suspension was 
centrifuged at 300 g for 10 min. The cells were incubated in PBS/1% BSA, including 0.1% IgG 
from rat serum for 30 min (Sigma-Aldrich, St. Louis, USA). Afterwards, the cells were stained with 
anti-CD14 FITC (Clone: 62D3), anti-CD16 APC (Clone: eBioCD16), anti-HLA-DR PerCP-Cy5.5 
(Clone: LN3, eBioscience), and anti-CD86 PE (Clone: 2331 (FUN-1), BD Bioscience, San Diego, 
USA). The flow cytometry analysis was performed using BD FACS Canto, followed by FACS Diva 
software (BD Biosciences) and FlowJo V10 software (FLOWJO LLC, Ashland, USA). The 
cytokine and chemokine concentrations in the cell culture supernatant were measured by ELISA 
(CXCL5/ENA-78 and CXCL6/GCP-2; both R&D Systems, Minneapolis, USA) and Multiplex 
Immunoassay TNF, IL-1, IL-6, IL-10 (all R&D Systems). 
2.3 RNA extraction 
 
RNA from lysed monocytes was extracted using the AllPrep DNA/RNA Mini Kit from QIAGEN 
following the manufacturer`s instruction. For quality control RNA concentrations were measured 
using NanoDrop (PeqLab, Erlangen, Germany) and degradation via Bioanalyzer (RIN 7; Agilent 
Technologies, Santa Clara, USA).  
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2.4 Transcriptome analysis 
 
The Illumina TotalPrep RNA Amplification Kit (Life Technologies) was used to amplify and 
biotinylate the RNA. Whole transcriptome profiling was performed on Illumina’s HT-12v4 bead 
arrays (Illumina, San Diego, USA), comprising 47.231 transcripts.  
The statistical analysis was performed using functions implemented in the statistical software R 
(version 3.1.0) and Bioconductor packages. Expression data was normalized using the limma 
package (Ritchie et al., 2015) and subsequently log-transformed. Only probes that obtained a 
detection P value <0.05 in at least 5% of all samples were taken into account. The selected 
expression probes were then filtered for a perfect or good probe quality, as reported in the 
Bioconductor package illuminaHumanv4.db (Barbosa-Morais et al., 2010). After quality control 
and filtering, data for 18.452 expression probes from up to 20 individuals was included in the 
analysis. Differentially expressed probes were calculated using limma (Ritchie et al., 2015), 
applying a paired design in the ANOVA analysis to identify the contrast between controls and 
stimulated samples. All nominal P values P were adjusted for multiple testing using Benjamini-
Hochberg correction in order to control for false discovery if not reported otherwise. Only probes 
with a fold-change (FC) ≥ 1.5 were selected in line with the microarray sensitivity of 1.35. The 
fold-change was calculated by dividing the mean intensity of the expression of a target gene of 
one group by the expression intensity of the same gene from the group it was compared with. If 
this number was <1, the negative reciprocal was used. The hierarchical cluster analysis was 
performed using the cluster method in R on z-transformed probes. Distances of the samples were 
calculated using Pearson correlation and clusters were formed by taking the average of each 
cluster.  
2.5 Pathway analysis 
 
Data evaluations were performed using Ingenuity Pathway Analysis (IPA® Systems Inc., 
Redwood City, USA). Each gene is represented in a global molecular network designed by 
information and provided by the Ingenuity Pathways Knowledge Base. “Networks” were 
generated algorithmically based on their connectivity concerning activation, expression and 
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transcription. Molecular relationships between genes are visible as connecting lines between 
nodes supported by published data stored in Ingenuity Pathways Knowledge Base and/or 
PubMed. Enriched GO and KEGG pathways, Protein-Protein-Interaction networks and 
associated diseases were calculated using the WEB-based GEne SeT AnaLysis Toolkit 
(WebGestalt, (Wang et al., 2013)), using all analyzed probes (n=18,452) as the background 
reference, a minimum of 3 genes per category and a FDR of 1% as the threshold for significance. 
2.7 Data management and statistical analysis 
 
The flow cytometry analysis was performed by BD FACS Canto and BD FACS Diva 6.0 (BD 
Bioscience) and analyzed by FlowJo v10 software (Tree Star, Ashland, USA). The ELISA was 
performed according the manufacturer`s instructions using SpectraMAX 190 and SoftMax Pro 6.5 
(Molecular Devices, Sunnyvale, USA). The Multiplex Immunoassays were performed using a 
xMAP MAGPIX system according to the manufacturer`s instruction (Luminex Corporation, Austin, 
USA). The statistical analysis was performed using Prism GraphPad 5.01 (GraphPad Software, 
San Diego, USA). 
All murine experiments with multiple groups were tested for significance by the Kruskal-Wallis 
test, followed by Dunn post hoc multiple comparisons. The differences between two unpaired 
groups were tested for statistical significance with the two-tailed Mann–Whitney U test. The 
differences between two paired groups were tested for statistical significance with the paired t-
test. The two-way ANOVA and Bonferroni post hoc test was used to test for significances of 
multiple groups over time. Significance is defined as P value < 0.05 (*<0.05; **<0.01, ***<0.001) 
and the error bars represent means ± SEM.  
Secreted protein and surface marker expression profiles of the human study were analyzed by 
ANOVA, followed by the Bonferroni Comparison Test. The data are shown as mean with SEM 
and P value of 5% was considered as statistically significant. 
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Results 
 
3.1 Impact of eosinophil granulocytes on E. coli-induced sepsis 
 
Helminths modulate inflammatory responses, thus providing protection against sepsis (Hübner et 
al., 2013). Eosinophil granulocytes are a hallmark of parasitic infections (Huang and Appleton, 
2016) and reveal anti-bacterial properties in vitro and in vivo (Linch et al., 2009; Yousefi et al., 
2008). Eosinophil numbers have been discussed as a marker of sepsis severity in the past. The 
challenges of anti-sepsis therapies are the control of systemic inflammation, especially during 
severe sepsis or septic shock, and the need to provide anti-bacterial properties without worsening 
the compensatory phase. Accordingly, in our recent publication we presented both improved 
bacterial killing and reduced systemic inflammation during the SIRS phase and thus increased 
the survival of E. coli-induced sepsis in chronic L. sigmodontis infected mice (Gondorf et al., 
2015). Consequently, one aim of this thesis was to explore the impact of eosinophil granulocytes 
on the outcome of an E. coli-induced sepsis during the SIRS phase. Additionally, TGF 
independent protection of L. sigmodontis infection on E. coli-induced sepsis is presented in 
complimentary project A. 
 
3.1.1 Absence of eosinophil granulocytes exacerbates E. coli-induced sepsis in ∆dblGATA mice  
 
Since earlier reports showed evidence that eosinopenia is a diagnostic marker of sepsis mortality 
in humans (Merino et al., 2012; Terradas et al., 2012) and because eosinophils respond to 
bacteria, the outcome of an E. coli–induced sepsis in eosinophil-deficient ∆dblGATA mice was 
compared to age-matched BALB/cJ controls. The development of hypothermia was monitored for 
six hours. Afterwards, the peritoneal bacterial load, sepsis-related peripheral blood chemokine 
and cytokine concentrations, relative numbers of T cells and myeloid derived cells including 
granulocytes, monocytes, macrophages and dendritic cells were analyzed. Shown data are 
pooled from two independent experiments (Fig. 6).  
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Figure 6: Absence of eosinophils in ∆dblGATA mice exacerbates sepsis outcome compared to controls. Development of 
hypothermia (A), bacterial load (B) and the concentration of systemic levels of CXCL1 (KC), CXCL2 (MIP-2) and IL-6 (C) six hours 
after injection of 3x107 CFU E. coli in wildtype and eosinophil-deficient ∆dblGATA mice (n=9-12 per group) are presented. The 
relative numbers of CD4+ and CD8+ cells are shown in (D) and the relative numbers of SiglecF+ eosinophils, Ly6G+Ly6C+ neutrophils, 
CD11b+F4/80+ macrophages, Ly6C+Ly6G- monocytes and CD11b+CD11c+ dendritic cells are displayed in (E). Statistical significances 
were tested by Mann-Whitney-test (B-E) or Two-way ANOVA (A) (*p<0.05, **p<0.01, ***p<0.001). 
 
Starting four hours after the E. coli injection, the body temperature was significantly reduced in 
∆dblGATA mice (n=12) compared to wild type controls (n=9) (Fig. 6A). Accordingly, the peritoneal 
bacterial load of ∆dblGATA mice was by tendency increased (Fig. 6B; p=0.0575). Systemic 
chemokine and cytokine concentrations of CXCL2 (MIP-2; p=0.0171) and IL-6 (p=0.0050) were 
significantly increased in ∆dblGATA mice compared to the controls (Fig. 6C), whereas differences 
in CXCL1 (KC) levels did not reach statistical significance (p=0.4550). As expected, the relative 
and absolute numbers of SiglecF+ eosinophils were significantly reduced in ∆dblGATA mice (Fig. 
6E; p=0.0001). Moreover, the frequency of peritoneal CD4+, CD8+ cells (Fig. 6D; both p=0.0007) 
and Ly6G+Ly6C+ neutrophils (Fig. 6E; p=0.0142) were significantly reduced in ∆dblGATA mice 
six hours after E. coli injection compared to controls. However, absolute numbers of peritoneal 
CD4+ (p=0.2883), CD8+ (p=0.1452) as well as neutrophils (p=0.1886) were not significantly 
decreased in eosinophil-deficient mice.  
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In contrast, absolute, but not relative, numbers of CD11b+F4/80+ macrophages were significantly 
decreased (p=0.0302) in ∆dblGATA mice (Fig. 6E). Both relative (Fig. 6E, p=0.4555) and absolute 
numbers of Ly6C+ monocytes (p=0.2410) were not reduced, whereas the relative (Fig. 6E, 
p=0.0012) and absolute numbers of CD11c+ dendritic cells (p=0.0062) were significantly reduced 
in eosinophil-deficient mice six hours after E. coli injection. These data indicate that eosinophils 
are contributing to a protective effect during a bacterial sepsis by lessening sepsis induced 
inflammation and the development of hypothermia. Furthermore, eosinophils seem to support 
anti-bacterial responses and the recruitment and maintenance of innate and adaptive cell types 
to the site of inflammation.  
 
3.1.2 Ex vivo generation of bone-marrow-derived eosinophil granulocytes 
 
To analyze whether an adoptive eosinophil transfer can improve sepsis outcome and since 
eosinophils are a hallmark of Th2 driven immune responses as they occur during parasitic 
helminth infections and allergies, a modified method to generate high numbers of bone-marrow 
derived and IL-5-induced functionally competent eosinophil granulocytes (bmEos) in high purity 
ex vivo was established (Dyer et al., 2008). Bone-marrow cells of naïve BALB/c mice were 
cultured with 100 µg/mL stem cell factor (SCF), 100 µg/mL FMS-like tyrosine kinase 3 ligand 
(FLT3L) for four days, followed by a 20 µg/mL IL-5 stimulation for eight additional days. 
Twelve days after the cultivation analysis by scanning electron microscopy, light microscopy using 
H&E staining and flow cytometry revealed a homogenous single-cell population of mature IL-5-
induced eosinophil granulocytes (Fig. 7A-C) with a purity of more than 98% SiglecF+CCR3+ cells 
(Fig. 7D) and simultaneously less than 4% Annexin V or Propidium iodide positive apoptotic and 
necrotic cells (Fig. 7E). 
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Figure 7: Representatives of ex vivo generated bone-marrow derived eosinophil granulocytes. Scanning electron microscopy 
(SEM) picture of a single cell (A) and the homogenous cell population (B) (SEM Pictures were taken by Alexandra Ehrens (AG 
Hübner) in the lab of Dr. Coralie Martin at the Muséum National d’Histoire Naturelle, Paris, France). Representative light 
microscopy picture of hematoxylin and eosin stained cell culture at day 12 (C). Additionally, the cells were stained for flow 
cytometry and analyzed for SiglecF and CCR3 (D) as well as for Annexin V and Propidium iodide (E) demonstrating a high purity 
(>95%) and low apoptosis (<5%). 
 
3.1.3 Impact of chemoattractant eotaxins on TLR4 and TLR1/2-driven responses of bmEos 
 
Eosinophil granulocytes are predominantly guided by chemokines like eotaxins via the blood 
stream to the place of inflammation and infection (Huang and Appleton, 2016). To investigate 
whether bmEos require priming or pre-activation before an adequate anti-bacterial response, we 
examined the consequences of chemoattractants on the responsiveness to TLR1/2, TLR4 ligands 
and filarial extracts in vitro.  
BmEos were treated by either CCL11 (eotaxin-1) or CCL24 (eotaxin-2) for 24 hours, followed by 
TLR4 agonist LPS E. coli ultrapure, TLR 1/2 agonist Pam3CSK4 (P3C) and the crude extract of 
murine filarial pathogenic Litomosoides sigmodontis (LsAg) re-stimulation for another 24 hours. 
Single stimulations and unstimulated bmEos served as controls and the secreted mediators were 
measured in the supernatant by ELISA. Pooled data of two independent experiments with the 
same outcome were statistical analyzed by Kruskal-Wallis test (Fig. 8).  
FMOs + unstained cells SiglecF+CCR3+ cells 
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Figure 8: Impact of recruitment factors CCL11 and CCL24 on the TLR1/2, TLR 4 and response to crude filarial antigen extract of 
bmEos. The levels of IL-6 (A), KC/CXCL1 (B), RANTES/CCL5 (C) and IL-4 (D) in the supernatant after stimulation are shown. BmEos 
were treated by eotaxin-1/CCL11 or eotaxin-2/CCL24 for 24 hours followed by 24h re-stimulation with LPS, Pam3CSK4 (P3C) or 
the crude Litosomoides sigmodontis extract (LsAg). Untreated cells served as controls. Data of two independent and pooled in 
vitro experiments with a total of seven replicates are shown. Data is presented on logarithmic scales as mean + SEM and analyzed 
for statistical significance using Kruskal-Wallis test (*p<0.05, **p<0.01, ***p<0.001). 
 
As shown in Figure 8, the P3C stimulation of bmEos resulted in elevated levels of pro-
inflammatory IL-6 (p<0.01), CXCL1 (p<0.001) and CCL5 (p<0.05) compared to unstimulated 
controls (Fig. 8A-C). The levels of IL-4 were not induced after P3C-only stimulation (Fig. 8D; 
p>0.05). The LPS stimulation increased the levels of IL-6 (p<0.05) and CCL5 (p<0.01) compared 
to unstimulated control (Fig. 8A+C). The priming of CCL11 and CCL24 did not alter the 
significantly increased release of IL-6, CXCL1 and CCL5, as well as IL-6 and CCL5 after P3C or 
LPS re-stimulation, respectively. Of notice, the pre-stimulation with CCL11 and CCL24 resulted 
in increased levels of CXCL1 after LPS re-stimulation that reached statistical significance for 
priming with CCL24 (Fig. 8B). Similarly, the combination of CCL24 and LsAg resulted in an 
increased release of IL-6 (p>0.05). Priming with CCL11 (p<0.05) and CCL24 (p<0.01) altered the 
release of IL-4 after LPS re-stimulation compared to LPS alone (Fig. 8D). Moreover, this effect 
was also observed for IL-4 concentrations measured from CCL24-primed and P3C re-stimulated 
compared to P3C-only stimulated bmEos (p<0.05). CCL24 treatment and LsAg re-stimulation 
significantly increased the release of IL-4 compared to unstimulated controls (p<0.05).  
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The pre-stimulation by the eotaxins CCL11 and CCL24 did not alter the release of the pro-
inflammatory neutrophil-recruitment factors IL-6, CXCL1 and CCL5, with the exception of LPS 
and CXCL1. The IL-4 levels were affected by CCL11 and CCL24 priming before re-stimulation 
with LPS and P3C. Accordingly, our results provide evidence that the TLR ligands P3C and LPS 
are potent eosinophil activators for the release of chemotactic mediators and previous eotaxin 
stimulation has no unique effect on type 1 and type 2 immune responses, but may be more 
important for type 2 immune responses. 
As CCL11 and CCL24 are bound to C-C chemokine receptor type (CCR) 3 (Sturm et al., 2013), 
it was further investigated whether 24 h of CCL24 treatment could alter the CCR3 expression of 
bmEos after six hours of P3C re-stimulation, which may indicate changes in the local recruitment 
of eosinophils. Additionally, Intercellular Adhesion Molecule 1 (CD54; ICAM-1) expression, which 
is involved in eosinophil adhesion and degranulation (Horie et al., 1997; Reimert et al., 1998), 
was examined. Consequently, bmEos were analyzed by flow cytometry for the expression of 
CCR3, ICAM-1 for cell recruitment and adhesion and CD69 for cell activation.  
As shown in Figure 9, the treatment with CCL24 resulted in a significant downregulation of CCR3 
expression on SiglecF+ cells independent of P3C stimulation (Fig. 9A+B; p<0.01). Furthermore, 
CD54/ICAM-1 expression was significantly induced after P3C stimulation, but independent of 
CCL24 priming (Fig. 9C+D; p<0.01). However, changes in CD69 expression were not observed 
(Fig. 9E+F; p>0.05).  
In summary, the stimulation with bacterial LPS and P3C altered the release of pro-inflammatory 
cytokines and chemokines of bmEos in vitro. Furthermore, especially CCL24 treatment selectively 
altered the responsiveness to LPS and P3C and reduced the expression of CCR3 on bmEos, 
whereas CCL24 priming did not alter ICAM-1 expression. 
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Figure 9: P3C stimulation and eotaxin-2/CCL24 priming alter CD54 and CCR3 expression of bmEos, respectively. Bone-marrow 
derived eosinophil granulocytes were treated by CCL24 for 24h followed by six hours stimulation with Pam3CSK4 (P3C). Histograms 
and MFI of CCR3 positive (A+B), CD54/ ICAM-1 positive (C+D) and CD69 positive (E+F) SiglecF+ eosinophil granulocytes are shown. 
Data of two independent and pooled in vitro experiments with a total of six replicates are shown and is presented as mean + SEM 
and analyzed for statistical significance using Kruskal-Wallis test (n=18, *p<0.05, **p<0.01, ***p<0.01). 
 
3.1.4 Anti-bacterial properties of bone-marrow-derived eosinophil granulocytes 
 
Since our experiments revealed that ex vivo differentiated bmEos respond to LPS and P3C with 
the release of pro-inflammatory mediators, we further investigated whether bmEos reduce the 
bacterial burden in vitro. Eosinophils reduce the bacterial burden by a spontaneous deposition of 
extracellular structures like extracellular mitochondrial DNA combined with eosinophil granule 
proteins in a process termed ETosis (Yousefi et al., 2008). Previous data demonstrate that human 
eosinophil granulocytes phagocytose bacteria, but with a lower capacity and more slowly 
compared to neutrophils (Cline et al., 1968; Yazdanbakhsh et al., 1986). Therefore, we examined 
the capability and mechanism of bmEos to reduce the bacterial burden one hour after the in vitro 
co-cultivation by scanning electron microscopy (SEM) (Fig. 10).  
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Figure 10: BmEos phagocytose E. coli and release extracellular structures. Scanning electron microscopy (SEM) representatives 
of bmEos incubated for one hour with E. coli ATCC 25922. Unstimulated controls (A), the released extracellular structures (white 
wedge) (B), phagocytosis of one bacteria (white wedge) (C) are presented. The pictures were taken by Alexandra Ehrens (AG 
Hübner) in the lab of Dr. Coralie Martin at the Muséum National d’Histoire Naturelle, Paris, France).  
 
Co-cultivation of bmEos and E. coli led to eosinophil-derived extracellular net-forming structures 
and phagocytosis-related cell arrangements compared to non-E. coli exposed controls (white 
wedges, Fig. 10A-C). The capacity of bmEos to reduce the bacterial burden in vitro was 
examined. 1x107 bmEos were co-cultured with 5x108 CFU E. coli for three hours. Generally, 
bmEos significantly reduced the number of E. coli in vitro (Fig. 11) (p=0.005), independent of prior 
treatment with the Golgi inhibitors Monensin and Brefeldin A or interferon  (data not shown). 
Those data indicate that eosinophils are implemented in protective immune responses against 
bacteria and provide a direct bactericidal effect which may contribute to the observed protective 
effect during a sepsis in vivo. 
 
Figure 11: BmEos reduce the number of bacteria in vitro. 1x107 bmEos were co-cultured with 5x108 E. coli bacteria for three 
hours. Pooled data of two independent experiments are shown (n=6 replicates). Data were analyzed by Mann-Whitney-test for 
significance (p=0.005). 
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3.1.5 Genome-wide transcriptome profiling of filarial-induced and non-induced murine 
eosinophil granulocytes in the absence or presence of an E. coli challenge 
 
In this thesis we demonstrated that pathogen-associated molecular patterns like LPS and P3C 
generates pro-inflammatory responses in bmEos and that the lack of eosinophils in ∆dblGATA 
mice worsen sepsis outcome. Thus, we further investigated whether a chronic filarial infection 
modifies the gene expression of murine eosinophils and whether eosinophil gene expression is 
affected during the acute phase of sepsis. Furthermore, we examined whether the local 
environment provides a specific transcriptional profile. Consequently, FSChi SSChi Hoechst 
33258neg CD11b+F4/80+SiglecF+ peritoneal and pleural eosinophil granulocytes from L. 
sigmodontis-infected BALB/c mice and uninfected controls were FACS sorted six hours after E. 
coli challenge and genome-wide mRNA sequencing was performed. Unchallenged mice served 
as controls.  
 
Figure 12: Hierarchical cluster analysis of FACS sorted FSChiSSChiHoechst33258negCD11b+F4/80+SiglecF+ pleural eosinophil 
granulocytes from L. sigmodontis-infected BALB/c mice six hours after 5x108 E. coli challenge or PBS injection (adj. P value < 
0.05 and FC ≥ 3; n=2-3 mice per group). Columns represent individual mice, whereas rows represent transcripts. Brown indicates 
high relative expression levels and blue indicates low relative expression levels. Cluster analysis was performed using Pearson’s 
correlation as distance measurement and average linkage. 
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Our initial results suggest that eosinophils of non-infected mice revealed a locus specific and E. 
coli treatment specific transcriptional profile. The E. coli challenge induced 39 differentially 
expressed transcripts in in eosinophils from the pleura of L. sigmodontis infected mice compared 
to eosinophils of non-E. coli challenged, L. sigmodontis infected mice (adjusted P value < 0.05 
and logarithmic fold change ≥ 3 with two to three mice per group; Fig. 12). The differential gene 
expression analysis revealed an up-regulation of genes (Rsad2↑, USP18↑ and ISG15↑) that are 
associated with interferon and interleukin 1 responses (Il1r2↑; Fig. 13 and Tab. 1). Moreover, the 
expression of transcripts of the apoptosis suppressor Bcl2↑, the pathogen and damaged cell 
detecting cell-surface receptor Clec4↑ and the interleukin-18 receptor accessory protein (Il18rap↑) 
were increased. Remarkably, Arg1↑, Chil3↑ and Resistin-like alpha (Retnla)↑ were induced in 
pleural eosinophils by the L. sigmodontis infection compared to gut-derived eosinophils (Fig. 14, 
Fig. 15 and Tab. 2). However, following E. coli challenge, the transcripts Arginase-1 (Arg1)↓ and 
Chitinase-like protein 3 (Chil3)↓ were downregulated in comparison to eosinophils from non-E. 
coli challenged, L. sigmodontis-infected mice (Fig. 12 and Tab. 1).  
 
 
 
Figure 13: Eosinophils derived from L. sigmodontis infected versus L. sigmodontis infected and E. coli challenged mice reveal 
39 differentially expressed genes. The fold change (x-axis) versus the P value (y-axis) is shown in a volcano plot analysis. Orange 
dots represent differentially expressed genes (FC ≥ 2.5 and adjusted P value < 0.05) while blue dots represent genes that were 
non-significant altered (FC ≥ 2.5 and adjusted P value > 0.05). 
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Table 1: 39 differentially expressed genes were detected in pleural eosinophils of E. coli challenged, L. sigmodontis infected 
mice compared to L. sigmodontis infected mice (L.s. inf. +E. coli vs. L.s. inf. w/o E. coli) (P value < 0.05; FC ≥ 3). 
ID/ Transcript Symbol logFC adj. P Value 
ENSMUSG00000020641 Rsad2 4,74340631 0,02994141 
ENSMUSG00000030107 Usp18 4,4867181 0,01465119 
ENSMUSG00000035692 Isg15 4,47297817 0,01436471 
ENSMUSG00000029534 St7 4,38342525 0,0491068 
ENSMUSG00000026073 Il1r2 4,37682175 0,00547947 
ENSMUSG00000004609 Cd33 4,21757108 0,00547947 
ENSMUSG00000033355 Rtp4 3,87545246 0,00208824 
ENSMUSG00000029322 Plac8 3,67152593 0,03614274 
ENSMUSG00000032690 Oas2 3,62550806 0,03578469 
ENSMUSG00000034833 Tespa1 3,60452583 0,02994141 
ENSMUSG00000003541 Ier3 3,49370319 0,00738762 
ENSMUSG00000027580 Helz2 3,44470097 0,02994141 
ENSMUSG00000045538 Ddx28 3,35553482 0,00924954 
ENSMUSG00000112895 RP23-304C21.3 3,31287212 0,03267535 
ENSMUSG00000057329 Bcl2 3,28684254 0,02224129 
ENSMUSG00000030142 Clec4e 3,23737771 0,02994141 
ENSMUSG00000031155 Pim2 3,19923808 0,0377336 
ENSMUSG00000026068 Il18rap 3,12729791 0,02474535 
ENSMUSG00000053007 Creb5 3,0955683 0,03464101 
ENSMUSG00000024222 Fkbp5 3,01589631 0,02945313 
ENSMUSG00000015850 Adamtsl4 3,00350131 0,0491068 
    
ENSMUSG00000048022 Tmem229a -3,10413747 0,0491068 
ENSMUSG00000027199 Gatm -3,16401518 0,03799554 
ENSMUSG00000027111 Itga6 -3,45003611 0,03799554 
ENSMUSG00000021477 Ctsl -3,52138468 0,0491068 
ENSMUSG00000037095 Lrg1 -3,71127403 0,03799554 
ENSMUSG00000020017 Hal -3,78738844 0,02945313 
ENSMUSG00000026938 Fcna -3,89618837 0,02945313 
ENSMUSG00000036887 C1qa -4,03892091 0,0491068 
ENSMUSG00000036896 C1qc -4,13610053 0,0491068 
ENSMUSG00000031596 Slc7a2 -4,57621844 0,01436471 
ENSMUSG00000040809 Chil3 -4,73038329 0,00224281 
ENSMUSG00000074622 Mafb -5,48708854 0,02395874 
ENSMUSG00000019987 Arg1 -5,54046603 0,01411056 
ENSMUSG00000026193 Fn1 -5,5746639 0,00208824 
ENSMUSG00000026748 Plxdc2 -5,9641843 0,0491068 
ENSMUSG00000004698 Hdac9 -6,21727061 0,04953091 
ENSMUSG00000015854 Cd5l -6,28659083 0,01044002 
ENSMUSG00000022122 Ednrb -6,84677601 0,0377336 
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Figure 14: Hierarchical cluster analysis of FACS sorted FSChiSSChiHoechst33258negCD11b+F4/80+SiglecF+ pleural eosinophil 
granulocytes from L. sigmodontis-infected BALB/c mice compared to uninfected intestinal eosinophils without E. coli challenge 
(adj. P value < 0.05 and FC ≥ 3; n=2-3 mice per group). Columns represent individual mice, whereas rows represent transcripts. 
Brown indicates high relative expression levels and blue indicates low relative expression levels. Cluster analysis was performed 
using Pearson’s correlation as distance measurement and average linkage. 
 
 
 
Figure 15: Eosinophils derived from the pleura of L. sigmodontis infected versus intestinal eosinophils of uninfected controls 
revealed 647 differentially expressed genes. The fold change (x-axis) versus the P value (y-axis) is shown in a volcano plot analysis. 
Orange dots represent differentially expressed genes (FC ≥ 3 and adjusted P value < 0.05) while blue dots represent genes that 
were non-significant altered (FC ≥ 3 and adjusted P value > 0.05). 
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Table 2: The L. sigmodontis infection induced 647 differentially expressed genes in pleural eosinophils compared to intestinal 
eosinophils from uninfected controls (L.s. inf. pleura vs. uninfected intestine) (P value < 0.05; FC ≥ 3). The top 5 up-regulated 
and downregulated transcripts are presented. 
ID/ Transcript Symbol logFC adj. P Value 
ENSMUSG00000019987 Arg1 11,55457936 0,010746584 
ENSMUSG00000040809 Chil3 11,43566765 0,0076202 
ENSMUSG00000015854 Cd5l 11,11875599 0,02626452 
ENSMUSG00000040026 Saa3 10,97756454 0,037889887 
ENSMUSG00000061100 Retnla 10,63012459 0,006565505 
    
ENSMUSG00000030017 Reg3g -8,367517561 0,004581137 
ENSMUSG00000049350 Zg16 -8,462132772 0,013788715 
ENSMUSG00000020405 Fabp6 -8,487285808 0,006565505 
ENSMUSG00000071356 Reg3b -8,535966189 0,006808938 
ENSMUSG00000095079 Igha -9,13657624 0,00809737 
 
Our results indicate that the transcriptome of eosinophils is altered upon experimental L. 
sigmodontis infection and differs from eosinophils derived from the gut of naïve mice as well as 
pleural eosinophils from L. sigmodontis infected animals after E. coli challenge. Future studies 
should hereby compare the impact of systemic and local modulation of eosinophil responses by 
the filarial infection. Therefore, gut-derived eosinophils should be analyzed for their modulation in 
response to the L. sigmodontis infection. Furthermore, experiments comparing pleural and 
peritoneal eosinophil granulocytes from non-L. sigmodontis infected and E. coli-treated or 
untreated mice as well as peritoneal eosinophils from L. sigmodontis and E. coli challenged mice 
have to be repeated, as those cells had to be excluded from the analysis due to the obtained low 
quantity of mRNA (<250 pg/µl). 
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3.2 Genome-wide transcriptional profiling of human monocytes stimulated with Brugia malayi 
crude extract and LPS reveals link to IL-17 associated pathways and diseases  
 
More than 150 million people worldwide are infected with filarial nematodes causing LF and 
onchocerciasis (WHO, 2015). Helminth parasites modulate cellular immune responses to ensure 
their survival and reproduction. Consequently, human monocytes from twenty healthy male, non-
endemic Caucasian volunteers were exposed to the crude extract of human pathogenic filaria B. 
malayi (BmA) before Escherichia coli LPS ultrapure stimulation. A genome-wide transcriptional 
profiling of more than 47.000 transcripts was performed by Illumina® HumanHT-12 v4 Expression 
BeadChip technology. Those results were supplemented with flow cytometry analysis and ELISA. 
Gene Set Enrichment Analysis using Ingenuity IPA© analysis, Gene Ontology enrichment 
analysis and Protein-Protein Interaction Analysis were performed to identify associations to 
immune functions and inflammatory disorders that potentially contributes to the development of 
filaria-caused pathology.  
 
3.2.1 Experimental design and human CD14+ monocyte purification 
 
To examine the immunomodulatory effect of BmA on subsequent LPS stimulation, CD14+ 
monocytes were purified using a Percoll gradient, followed by magnetic cell separation (MACS). 
Two hours after separation the cells were stimulated by BmA for 18 h followed by a subsequent 
stimulation with LPS for an additional 6 h (Fig. 16A). Corresponding BmA or LPS ultrapure E. coli 
only stimulated samples served as controls. 24 hours after stimulation the cells were harvested, 
lysed and an RNA purification was performed. MACS of human monocytes reached more than 
95% purity, the overnight monocyte apoptosis was less than 8% Annexin V+ or Propidium iodide 
+ cells (Fig. 16B+C). 
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Figure 16: Experimental setup and stimulation scheme of the transcriptomic profiling approach is presented in A. The 
purification after CD14+ monocyte separation of healthy human non-endemic volunteers is shown in (B) and the overnight viability 
of separated monocytes is displayed in (C).  
 
3.2.2 BmA stimulation alone significantly induced transcripts in human monocytes compared to 
unstimulated controls 
 
To examine whether BmA can induce differentially expressed genes (P value < 0.05; FC ≥ ±1.5), 
BmA-only stimulated human monocytes were analyzed 24 h after stimulation and compared to 
unstimulated controls (BmA vs. control). 42 transcripts were nominally significant induced by BmA 
treatment, but did not withstand correction for multiple testing.  
Members of the metallothionein family↑, indoleamine 2,3-dioxygenase 1 (INDO/IDO1)↑, TNF 
alpha induced protein 6 (TNFAIP6)↑, leukocyte immunoglobulin like receptor A3 (LILRA3)↑, C-C 
motif chemokine ligand 23 (CCL23)↑, interleukin 8, C-X-C motif chemokine ligand 8 (IL8/CXCL8)↑ 
and signal transducer and activator of transcription 1 pathway (STAT1)↑ were upregulated upon 
BmA treatment. In contrast, albumin (ALB)↓, CAMPATH-1 antigen (CD52)↓, ribonuclease P RNA 
component H1 (RPPH1)↓, and Fc fragment of IgE receptor 1α (FCER1A)↓ and genes of the 
SNOR- and RNU-family↓ were differentially downregulated (Tab. 3).  
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Table 3: Stimulation with Brugia malayi crude extract (BmA) induced 42 significantly expressed transcripts in human monocytes 
24 h after treatment compared to unstimulated controls (P value < 0.05; FC ≥ 1.5).  
ID/Transcript Gene Definition Adj. P Value FC 
ILMN_1715401 MT1G metallothionein 1G  2,03E-05 3,04 
ILMN_2124802 MT1H metallothionein 1H  3,10E-05 2,99 
ILMN_1718766 MT1F metallothionein 1F  3,16E-05 2,43 
ILMN_2173611 MT1E metallothionein 1E  0,0004463 2,32 
ILMN_1686664 MT2A metallothionein 2A  0,00071025 2,14 
ILMN_1691156 MT1A metallothionein 1A  0,00068149 2,09 
ILMN_1775170 MT1X metallothionein 1X  0,00060765 2,05 
ILMN_1656310 INDO indoleamine 2,3-dioxygenase 1  0,01480863 1,96 
ILMN_1657435 MT1M metallothionein 1M  0,00474874 1,94 
ILMN_3239965 IDO1 indoleamine 2,3-dioxygenase 1  0,02005119 1,91 
ILMN_1686109 CCL23 C-C motif chemokine ligand 23  0,00030124 1,77 
ILMN_1769388 GJB2 gap junction protein beta 2  6,09E-05 1,75 
ILMN_3237878 LOC100133875 similar to Leukocyte immune-globulin-like 
receptor, subfamily A (without TM domain), 
member 3 
0,01584309 1,68 
ILMN_1785732 TNFAIP6 TNF alpha induced protein 6  0,00256657 1,68 
ILMN_1786303 LILRA3 leukocyte immunoglobulin like receptor A3  0,01752226 1,66 
ILMN_1776188 MAP1LC3A microtubule associated protein 1 light chain 3 
alpha  
0,00252913 1,61 
ILMN_1662640 C20orf127/MT1P3 metallothionein 1 pseudogene 3  0,00360858 1,61 
ILMN_3307868 CHI3L1 chitinase 3 like 1  0,00016417 1,61 
ILMN_1764030 CCL23 C-C motif chemokine ligand 23 0,00169947 1,56 
ILMN_1691364 STAT1 signal transducer and activator of 
transcription 1  
0,02646289 1,56 
ILMN_1690105 STAT1 signal transducer and activator of 
transcription  
0,03108525 1,54 
ILMN_1661631 LILRA3 leukocyte immunoglobulin like receptor A3  0,04043949 1,54 
ILMN_1695316 SLC39A8 solute carrier family 39 member 8  0,00504967 1,51 
ILMN_2184373 IL8 / CXCL8 interleukin 8, C-X-C motif chemokine ligand 8 0,00468001 1,50 
ILMN_1713832 SNORD15B small nucleolar RNA, C/D box 15B 0,0015155 -1,51 
ILMN_2082762 SNORD68 small nucleolar RNA, C/D box 68 0,00135061 -1,52 
ILMN_3309759 VTRNA1-1 vault RNA 1-1 0,00228141 -1,52 
ILMN_1684982 PDK4 pyruvate dehydrogenase kinase 4 7,96E-06 -1,53 
ILMN_3244640 SNORD96A small nucleolar RNA, C/D box 96A 0,00084078 -1,57 
ILMN_3249167 SNORA63 small nucleolar RNA, H/ACA box 63 0,00244951 -1,59 
ILMN_3240594 RNU4ATAC RNA, U4atac small nuclear (U12-dependent 
splicing) 
0,00561025 -1,59 
ILMN_2208903 CD52 CD52 molecule 0,00280334 -1,62 
ILMN_1782939 ALB albumin 0,00672508 -1,62 
ILMN_3238435 SNORA12 small nucleolar RNA, H/ACA box 12 0,02534893 -1,63 
ILMN_1901419 RNU11 RNU11, RNA, U11 small nuclear 0,00292359 -1,64 
ILMN_3246209 SCARNA10 small Cajal body-specific RNA 10 0,00383962 -1,66 
ILMN_1908824 RNU6ATAC RNA, U6atac small nuclear (U12-dependent 
splicing) 
0,01291778 -1,66 
ILMN_3241878 RNU6ATAC RNA, U6atac small nuclear (U12-dependent 
splicing) 
0,00870081 -1,68 
ILMN_1704056 RPPH1 ribonuclease P RNA component H1 0,00643212 -1,75 
ILMN_3245103 RNU11 RNA, U11 small nuclear 0,00188116 -1,78 
ILMN_1768139 RNU12 RNA, U12 small nuclear 0,00262698 -1,78 
ILMN_3242405 RMRP RNA component of mitochondrial RNA 
processing endoribonuclease 
0,00048553 -1,81 
ILMN_1688423 FCER1A Fc fragment of IgE receptor Ia 8,21E-05 -1,82 
ILMN_1682402 SNORD46 small nucleolar RNA, C/D box 46 0,00268996 -1,89 
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3.2.3 High similarity in the transcriptional profiles of LPS-only and BmA+LPS re-stimulated 
monocytes compared to unstimulated controls 
 
Similarities in the transcriptional profiles of LPS-only and combined BmA+LPS stimulated 
monocytes (LPS vs. control and BmA+LPS vs. control) were further analyzed. Our results 
supported previous findings of LPS-only stimulated human monocytes (Kim et al., 2014). 
Accordingly, differentially expressed genes (P value < 0.05; FC ≥ ±1.5) were involved in 
inflammation and inflammasome activation. Furthermore, increased levels of C-X-C motif 
chemokine ligand 1 (CXCL1/ NAP-3)↑, C-C motif chemokine ligand 19 (CCL19/ MIP3B)↑, tumor 
necrosis factor superfamily member 12 (TNFSF12)↑, but also cytokines like interleukin 1 beta (IL-
1B)↑ and interleukin 6 (IL-6)↑ were induced. 
The BmA treatment and LPS re-stimulation resulted in 1,979 differentially expressed genes 
(BmA+LPS vs. control), whereas LPS alone stimulation resulted in 2,215 differentially expressed 
genes (LPS vs. control) compared to unstimulated controls. By comparing both conditions, a high 
overlap of 1,862 differentially expressed genes with a high concordance across fold-changes 
(r²=0.98) was identified (Fig. 17A). 335 transcripts were regulated exclusively in LPS-only 
stimulated cells in contrast to 117 transcripts in BmA primed and LPS re-stimulated cells 
compared to control (Fig. 17B). 
 
Figure 17: High overlap of 1,862 differentially expressed genes and concordance across fold-changes in human monocytes after 
stimulation with BmA+LPS re-stimulation and LPS-only stimulation versus unstimulated controls.  
r²=0.98 
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The Log2 fold-change (FC) for LPS versus unstimulated control against the log2 FC for B. malayi extract (BmA) plus LPS re-
stimulation versus unstimulated control is shown in A (FC ≥ 1.5 and corrected P value < 0.05). Orange lines show a fold-change ≥ 
1.5 and the correlation of both FCs is r²=0.98. In addition, the data sets are presented as Venn diagram of differentially expressed 
transcripts presenting the high overlap of LPS and BmA+LPS versus control.  
 
3.2.4 BmA treatment modulates gene expression in human monocytes after LPS stimulation 
 
It was further examined whether BmA treatment of human monocytes can modify TLR4-
responses. Evidence was previously reported for soluble Schistosoma mansoni egg antigens 
(Kane et al., 2004; Kane et al., 2008), Fasciola hepatica defense molecule 1 (FhDM-1) (Robinson 
et al., 2011) and Chitohexaose derived from Setaria digitata (Panda et al., 2012).  
Consequently, the immunomodulatory effect of BmA priming on pro-inflammatory LPS responses 
was analyzed by comparing human monocytes primed with BmA for 18 h and LPS re-stimulation 
for six hours directly to LPS-only stimulated monocytes (BmA+LPS vs. LPS).  
After multiple test correction only pentraxin 3 (PTX3/TSG-14)↓, a member of the pentraxins 
superfamily and a multifunctional soluble pattern recognition receptor, was significantly reduced 
(P value < 0.05; FC ≥ ±1.5). 29 downregulated and 19 upregulated transcripts were altered at 
nominal significance, resulting in 49 differentially expressed transcripts overall (Tab. 4, Fig. 18A). 
In addition, a hierarchical cluster analysis of differentially expressed genes was performed to 
analyze subjects and transcripts using Pearson’s correlation as a distance measurement and 
average linkage (Fig. 18B). 
In line with our previous findings (BmA vs. control), members of the metallothionein family and 
members of the SNOR C/D box↓, SNOR H/ACA box↓ and RNU-family genes↓ were down-
regulated by BmA priming before LPS E. coli stimulation. ALB↓, TNFRSF21↓, CD52↓, and 
CCL20/MIP3α↓ were reduced.  
In contrast, the transcripts of the C-X-C motif chemokine ligands CXCL5/ENA-78↑, CXCL6/GCP-
2↑, and CXCL7/NAP-2/PPBP↑ were up-regulated. Additionally, the expression of C-type lectin 
domain family 4 member A (CD367/CLEC4A), as well as the matrix metalloproteinases MMP7↑ 
and MMP9↑, were up-regulated.  
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Table 4: Stimulation with Brugia malayi crude extract (BmA) before LPS re-stimulation induced 49 significantly expressed 
transcripts in human monocytes 24 h after treatment compared to LPS-only stimulated (P value < 0.05; FC ≥ 1.5).  
ID/Transcript Symbol Definition Adj. P Value FC 
ILMN_2171384 CXCL5 C-X-C motif chemokine ligand 5, ENA-78, SCYB5 0,16580403 2,56 
ILMN_2124802 MT1H metallothionein 1H 0,21755233 2,10 
ILMN_1752562 CXCL5 C-X-C motif chemokine ligand 5, ENA-78, SCYB5 0,19664078 2,08 
ILMN_1767281 PPBP pro-platelet basic protein, CXCL7; NAP-2 0,24213693 1,90 
ILMN_1657435 MT1M metallothionein 1M 0,36481335 1,80 
ILMN_1718766 MT1F metallothionein 1F 0,31856643 1,74 
ILMN_1796316 MMP9 matrix metallopeptidase 9,  0,07680070 1,70 
ILMN_1715401 MT1G metallothionein 1G 0,51871992 1,70 
ILMN_1779234 CXCL6 C-X-C motif chemokine ligand 6, GCP2 0,10022298 1,62 
ILMN_1709204 CLEC4A C-type lectin domain family 4 member A, CD367 0,14503500 1,58 
ILMN_1733579 EVI2A ecotropic viral integration site 2A 0,18209529 1,57 
ILMN_1780671 PLEKHG3 pleckstrin homology and RhoGEF domain 
containing G3 
0,13891895 1,56 
ILMN_1690342 LTA4H leukotriene A4 hydrolase 0,37794065 1,55 
ILMN_2161577 CXCL6 C-X-C motif chemokine ligand 6, GCP2 0,07680070 1,55 
ILMN_1740015 CD14 CD14 molecule 0,45457167 1,55 
ILMN_1689518 PECAM1 platelet and endothelial cell adhesion molecule 1 0,12248916 1,54 
ILMN_1735910 VMO1 vitelline membrane outer layer 1 homolog 0,33937674 1,53 
ILMN_1763452 EVI2B ecotropic viral integration site 2B 0,13891895 1,53 
ILMN_1690125 PDLIM7 PDZ and LIM domain 7 0,06134147 1,52 
ILMN_3246869 SCARNA21 small Cajal body-specific RNA 21 0,12483774 -1,51 
ILMN_2208903 CD52 CD52 molecule 0,41519934 -1,51 
ILMN_1801842 PTX3 pentraxin 3, TSG-14; TNFAIP5 0,03244278 -1,53 
ILMN_1691846 G0S2 G0/G1 switch 2 0,12483774 -1,53 
ILMN_3241021 RNY4 RNA, Ro-associated Y4 0,27347828 -1,54 
ILMN_3236049 SNORD12 small nucleolar RNA, C/D box 12 0,14863846 -1,54 
ILMN_1704730 CD93 CD93 molecule 0,45819779 -1,57 
ILMN_1689378 CCRN4L CCR4 carbon catabolite repression 4-like 0,07680070 -1,57 
ILMN_1699695 TNFRSF21 TNF receptor superfamily member 21 0,19664078 -1,58 
ILMN_2082762 SNORD68 small nucleolar RNA, C/D box 68 0,13891895 -1,60 
ILMN_1810462 C10orf115 chromosome 10 open reading frame 115 / 
Ba215c7.4 
0,14863846 -1,60 
ILMN_3244640 SNORD96A small nucleolar RNA, C/D box 96A 0,14503500 -1,62 
ILMN_3309759 VTRNA1-1 vault RNA 1-1 0,14863846 -1,62 
ILMN_1713832 SNORD15B small nucleolar RNA, C/D box 15B 0,12972666 -1,63 
ILMN_3240594 RNU4ATAC RNA, U4atac small nuclear (U12-dependent 
splicing) 
0,24872237 -1,65 
ILMN_1713751 ADAM19 ADAM metallopeptidase domain 19 0,30719616 -1,69 
ILMN_3249167 SNORA63 small nucleolar RNA, H/ACA box 63 0,13849379 -1,73 
ILMN_1657234 CCL20 C-C motif chemokine ligand 20 0,31270144 -1,74 
ILMN_1737709 RPL10L ribosomal protein L10 like 0,07680070 -1,76 
ILMN_3246209 SCARNA10 small Cajal body-specific RNA 10 0,17434420 -1,78 
ILMN_1901419 RNU11 RNA, U11 small nuclear 0,13891895 -1,79 
ILMN_3242405 RMRP RNA component of mitochondrial RNA processing 
endoribonuclease 
0,10022298 -1,90 
ILMN_3241878 RNU6ATAC RNA, U6atac small nuclear (U12-dependent 
splicing) 
0,17434420 -1,91 
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ILMN_3245103 RNU11 RNA, U11 small nuclear 0,13849379 -1,91 
ILMN_3238435 SNORA12 small nucleolar RNA, H/ACA box 12 0,22461734 -1,91 
ILMN_1704056 RPPH1 ribonuclease P RNA component H1 0,18209529 -1,92 
ILMN_1908824 RNU6ATAC  RNA, U6atac small nuclear (U12-dependent 
splicing) 
0,18003597 -1,94 
ILMN_1782939 ALB albumin 0,10022298 -1,96 
ILMN_1768139 RNU12 RNA, U12 small nuclear 0,12248916 -2,00 
ILMN_1682402 SNORD46 small nucleolar RNA, C/D box 46 0,12248916 -2,11 
 
 
Figure 18: BmA+LPS re-stimulation versus LPS-only stimulation of human monocytes resulted in 49 differentially expressed 
genes. The Log2 fold-change (x-axis) versus the log10 P value (y-axis) for B. malayi antigen (BmA) plus LPS re-stimulation versus 
LPS alone is shown in a volcano plot analysis (A) (see Table 2). Orange dots represent up-regulated while blue dots represent 
down-regulated differentially expressed genes (FC ≥ 1.5 and corrected P value < 0.05). The hierarchical cluster analysis of 
differentially expressed genes is shown in (B). Columns represent subjects, whereas rows represent transcripts. Red indicates high 
relative expression levels and blue indicates low relative expression levels. Cluster analysis was performed using Pearson’s 
correlation as distance measurement and average linkage. 
 
The overlap of transcriptional changes of BmA-only stimulated (BmA vs. control) and BmA primed 
and LPS re-stimulated cells (BmA+LPS vs. LPS) was analyzed to determine the differentially 
expressed transcripts that were individually altered (double detected transcripts were excluded) 
(Fig. 19). BmA+LPS compared to LPS stimulation resulted in 25 transcripts including CCL20, 
CXCL5-7, PTX3 and TNFRSF12. Members of the metallothionein family and the SNOR and RNU-
family in addition to albumin and CD52 were found in the overlay of both groups (BmA vs. control 
and BmA+LPS vs. LPS). Moreover, IL-8 and CCL23 beside STAT1 expression were found in 
BmA-only stimulated cells compared to unstimulated controls. 
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Figure 19: High correspondence of transcripts of B. malayi extract (BmA) only (BmA vs. control) compared to BmA+LPS 
stimulated human monocytes (BmA+LPS vs. LPS). Venn diagram showing the comparison of differentially expressed transcripts 
(FC ≥ 1.5 and P value < 0.05). 
 
3.2.5 BmA priming reduces CD86 and HLA-DR expression of LPS-stimulated human monocytes 
and triggers CXCL5 and CXCL6 release 
 
Since an L. sigmodontis–mediated protection against E. coli-induced sepsis is associated with 
reduced peritoneal macrophage activation (Gondorf et al., 2015), expression profiles of the co-
stimulatory cell activation marker B7-2 (also known as CD86) and the human leukocyte antigen - 
antigen D related (HLA-DR) on human monocytes were investigated by flow cytometry (n=8) (Fig. 
20). To confirm part of the data of the transcriptome analysis, released protein levels in the 
supernatants were measured by ELISA or Multiplex Assay (n=20). 
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Figure 20: BmA priming reduces CD86 and HLA-DR expression on human CD14+CD16- monocytes after LPS stimulation and 
increases CXCL5 and CXCL6 levels. The mean fluorescence intensity (MFI) of CD86 (A) and HLA-DR (B) of monocytes stimulated 
with BmA and/or LPS as well as unstimulated controls (n=8). Mean concentrations of IL-6 (C), IL-1β (D), TNF (E), CXCL5 (F), IL-10 
(G), and CXCL6 (H) in the supernatant after stimulation (n=20). Baseline concentrations of unstimulated controls were subtracted 
for each donor. Data are presented as mean + SEM and analyzed for statistical significance using ANOVA followed by Bonferroni 
Comparison Test (*p<0.05, **p<0.01, ***p<0.01). 
 
As shown in Figure 20A+B, LPS stimulation caused a significant increase of CD86 and HLA-DR 
expression (p<0.001). The BmA pre-exposure followed by LPS stimulation significantly reduced 
the CD86 (p<0.05) and HLA-DR (p<0.01) expression levels compared to LPS alone. BmA 
stimulation alone did not result in an altered expression of CD86 and HLA-DR (p>0.05). 
Furthermore, the release of IL-1 and IL-6 was not significantly altered upon BmA priming 
followed by LPS stimulation (p>0.05) (Fig. 20C+D). An increased release of TNF (p>0.05) and IL-
10 (p<0.01) was observed following LPS stimulation, but was not affected by BmA pre-treatment 
(p>0.05) (Fig. 20E+G). Increased levels of CXCL5 (p>0.01) and CXCL6 (p>0.05) caused by BmA 
priming before LPS stimulation confirmed our transcriptional profiles of up-regulated differentially 
expressed transcripts (BmA+LPS vs. LPS).  
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Furthermore, the apoptosis of human monocytes was reduced by the BmA treatment compared 
to unstimulated monocytes (Fig. 21A, p=0.0257, n=12). LPS-only stimulation also reduced the 
frequency of apoptotic cells (Fig. 21B) and previous BmA treatment did not affect the frequency 
of apoptotic cells upon LPS-restimulation compared to LPS-only stimulated cells (Fig. 21C, 
p=0.7051). 
 
Figure 21: The BmA treatment reduces apoptosis of human monocytes and does not alter reduced apoptosis after LPS 
stimulation. The frequency of Annexin5+ Propidium iodide+ cells after BmA-only stimulation (A), LPS-only (B) and in combination 
of BmA-priming and LPS stimulation of twelve donors is shown. The data were analyzed by Paired t test for significance. 
 
3.2.6 Pathway analysis of transcriptome profiles of BmA primed and LPS stimulated human 
monocytes reveals link to IL-17 associated pathways and diseases 
 
KEGG chemokine signaling pathway analysis 
To clarify whether BmA-induced differentially expressed genes are involved in biological 
pathways and diseases, gene enrichment analyses were performed. First, both sets of 
differentially expressed genes (BmA vs. control and BmA+LPS vs. LPS) were analyzed by Kyoto 
Encyclopedia of Genes and Genomes (KEGG) chemokine signaling pathway analysis (Tab. 5). 
BmA vs. control affected five pathways: chemokine signaling pathway, inflammation, bronchial 
diseases, bronchiolitis and immune system diseases. Pathway analysis of BmA+LPS vs. LPS 
revealed thirteen affected pathways, including the identified pathways of BmA vs. control except 
for immune system diseases. The analysis revealed pathways (BmA+LPS vs. LPS) that included 
arteriosclerosis and cardiovascular diseases like infarction.  
A B C 
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Table 5: Overview of pathways affected by BmA treatment alone (BmA vs. control) or followed by LPS stimulation (BmA+LPS 
vs. LPS) determined by KEGGs chemokine signaling pathway analysis. Differentially expressed genes (P value < 0.05; FC ≥ 1.5) 
of monocytes of human non-endemic controls (n=20) were analyzed. 
Comparison Category #Gene Symbol Statistics 
BmA vs. control Chemokine signaling pathway 3 STAT1, CXCL8, CCL23 C=145;O=3;E=0.46;R=6.49;rawP=0.0109;adjP=0.0109 
Inflammation 7 IDO1, TNFAIP6, FCER1A, 
CCL23, CXCL8, CHI3L1, STAT1 
C=278;O=7;E=0.89;R=7.90;rawP=2.30e-05;adjP=9.20e-05 
Bronchial Diseases 5 IDO1, FCER1A, CCL23, CXCL8, 
CHI3L1 
C=139;O=5;E=0.44;R=11.29;rawP=7.28e-05;adjP=0.0001 
Bronchiolitis 5 IDO1, FCER1A, CCL23, CXCL8, 
STAT1 
C=142;O=5;E=0.45;R=11.05;rawP=8.06e-05;adjP=0.0001 
Immune System Diseases 5 IDO1, FCER1A, CD52, CXCL8, 
CHI3L1 
C=407;O=5;E=1.30;R=3.85;rawP=0.0089;adjP=0.0089 
BmA+LPS vs LPS  Cytokine-cytokine receptor 
interaction 
5 CXCL5, CCL20, TNFRSF21, 
PPBP, CXCL6 
C=161;O=5;E=0.64;R=7.80;rawP=0.0004;adjP=0.0012 
Rheumatoid arthritis 3 CXCL5, CCL20, CXCL6 C=71;O=3;E=0.28;R=10.61;rawP=0.0028;adjP=0.0028 
Chemokine signaling pathway 4 CXCL5, CCL20, PPBP, CXCL6 C=145;O=4;E=0.58;R=6.92;rawP=0.0026;adjP=0.0028 
Inflammation 8 MMP9, CXCL5, CCL20, PTX3, 
CXCL6, CD14, PECAM1, PPBP 
C=278;O=8;E=1.11;R=7.22;rawP=1.19e-05;adjP=9.06e-05 
Bronchial Diseases 6 MMP9, CXCL5, CCL20, CXCL6, 
CD14, LTA4H 
C=139;O=6;E=0.55;R=10.83;rawP=1.71e-05;adjP=9.06e-05 
Respiratory Tract Infections 6 MMP9, CXCL5, CXCL6, CD14, 
PECAM1, PPBP 
C=144;O=6;E=0.57;R=10.46;rawP=2.09e-05;adjP=9.06e-05 
Infarction 5 MMP9, PTX3, CD14, PECAM1, 
LTA4H 
C=117;O=5;E=0.47;R=10.73;rawP=9.61e-05;adjP=0.0002 
Arteriosclerosis 5 MMP9, PTX3, CD14, PECAM1, 
PPBP 
C=121;O=5;E=0.48;R=10.37;rawP=0.0001;adjP=0.0002 
Arterial Occlusive Diseases 5 MMP9, PTX3, CD14, PECAM1, 
PPBP 
C=123;O=5;E=0.49;R=10.20;rawP=0.0001;adjP=0.0002 
Myocardial Infarction 5 MMP9, PTX3, CD14, PECAM1, 
LTA4H 
C=124;O=5;E=0.49;R=10.12;rawP=0.0001;adjP=0.0002 
Common Cold 5 MMP9, CXCL5, CXCL6, CD14, 
PPBP 
C=140;O=5;E=0.56;R=8.96;rawP=0.0002;adjP=0.0003 
Bronchiolitis 5 CXCL5, CXCL6, CD14, PECAM1, 
PPBP 
C=142;O=5;E=0.57;R=8.84;rawP=0.0002;adjP=0.0003 
Myocardial Ischemia 5 MMP9, ALB, PTX3, CD14, 
PECAM1 
C=142;O=5;E=0.57;R=8.84;rawP=0.0002;adjP=0.0003 
 
Gene Ontology enrichment analysis (GO) 
Furthermore, a Gene Ontology enrichment analysis (GO) and a Protein-Protein-Interaction 
networks (PPI) analysis was performed to link related genes to their functions (using WebGestalt) 
and to identify (highly) connected modules, respectively.  
As shown in Figure 22, BmA treatment before LPS stimulation (BmA+LPS vs. LPS) resulted in 
differentially expressed genes that were involved in biological processes like responses to 
inorganic substances (6 genes; adjusted P value (adjP)=1.20e-03), cellular response to cadmium 
(3 genes; adjP=1.00e-04) or zinc (4 genes; adjP=5.81e-07), phagocytosis (4 genes; adjP=6.00e-
04), but also immune system processes (11 genes; adjP=3.40e-03). In addition, BmA-only 
stimulation resulted in effects on molecular functions like carbohydrate binding (3 genes; 
adjP=2.20e-02), zinc ion binding (11 genes; adjP=9.30e-03), chemokine activity (4 genes; 
adjP=4.29e-05), and metallopeptidase activity (3 genes; adjP=6.50e-03).  
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The Gene Ontology enrichment analysis also revealed effects on cellular components like 
extracellular space (8 genes; adjP=2.00e-04) and platelet alpha granule (3 genes; adjP=1.00e-
03).  
Similarly, BmA-only stimulation (BmA vs. control) resulted in effects on inorganic substances (9 
genes; adjP=1.88e-07), including cadmium and zinc as well as carbohydrate derivate binding (3 
genes; adjP=5.80e-03). Effects on cellular components like extracellular space (4 genes; 
adjP=1.37e-01) were also determined. Effects on the perinuclear region of cytoplasm (8 genes; 
adjP=5.05e-06) were uniquely identified by BmA-only stimulation (data not shown). 
 
 
Figure 22: Gene Ontology (GO) enrichment analysis of differentially expressed genes (BmA+LPS vs. LPS) reveal associations to 
biological processes, molecular functions and cellular components with a minimum of 3 genes per GO term. 
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Protein-Protein Interaction analysis (PPI) 
A Protein-Protein Interaction analysis (PPI) of the 45 differentially induced genes by BmA 
treatment and LPS stimulation (BmA+LPS vs. LPS) revealed three highly connected nodules 
(CCL20, CXCL5 and CXCL6) that affected a diverse list of genes including chemokine receptors 
CCR2 or CXCR1 and chemokine ligands CXCL1 (Fig. 23).  
 
Figure 23: Protein-Protein Interaction analysis (PPI) of BmA and LPS vs. LPS stimulated differentially expressed genes 
discovered three highly connected modules (highlighted in green). The connected interaction partners are shown in white. 
 
Ingenuity® Pathway Analysis (IPA®) 
To identify disease-relevant pathways that were affected by B. malayi crude extract priming in the 
context of LPS stimulation, a Gene Set Enrichment Analysis using Ingenuity® Pathway Analysis 
was performed to identify canonical pathways with genes that were disproportionately highly 
enriched compared to randomly enriched genes. Consequently, 73 canonical pathways were 
identified with BmA alone stimulated human monocytes (BmA vs. control, Tab. 6), compared to 
55 canonical pathways by BmA treatment before LPS stimulation (BmA+LPS vs. LPS, Tab. 7). 
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BmA treatment alone revealed effects on Oncostatin M signaling (MT2A, CHI3L1, STAT1). In 
addition, pathways with two enriched genes include IL-6 signaling (CXCL8, TNFAIP6), 
atherosclerosis signaling (CXCL8, ALB), IL-12 signaling and production in macrophages (ALB, 
STAT1), Tec kinase signaling (FCER1A, STAT1), granulocyte and agranulocyte adhesion and 
diapedesis (CXCL8, CCL23), the production of nitric oxide and reactive oxygen species in 
macrophages (ALB, STAT1) and hepatic fibrosis / hepatic stellate cell activation (CXCL8, STAT1) 
and glucocorticoid receptor signaling (CXCL8, STAT1). Furthermore, associations to psoriasis, 
allergic inflammatory airway diseases, arthritis, and airway pathology in chronic obstructive 
pulmonary disease were detected (all CXCL8 only). In addition, an impact on IL-22, IL-15, IL-9, 
and interferon signaling was determined (all STAT1 only).  
Table 6: Ingenuity Canonical Pathways® analysis of differentially expressed genes of human monocytes that were treated with 
BmA only (BmA vs. control). List of pathways, P values and identified molecules are displayed. 
Ingenuity Canonical Pathways -log(P value) Molecules 
Oncostatin M Signaling 5,04E00 MT2A,CHI3L1,STAT1 
IL-6 Signaling 2,06E00 CXCL8,TNFAIP6 
Airway Pathology in Chronic Obstructive Pulmonary Disease 2,02E00 CXCL8 
Tryptophan Degradation to 2-amino-3-carboxymuconate Semialdehyde 2,02E00 IDO1 
Atherosclerosis Signaling 2,01E00 CXCL8,ALB 
IL-12 Signaling and Production in Macrophages 1,95E00 ALB,STAT1 
Tec Kinase Signaling 1,81E00 FCER1A,STAT1 
Role of IL-17A in Psoriasis 1,81E00 CXCL8 
NAD biosynthesis II (from tryptophan) 1,74E00 IDO1 
Granulocyte Adhesion and Diapedesis 1,71E00 CXCL8,CCL23 
Production of Nitric Oxide and Reactive Oxygen Species in Macrophages 1,7E00 ALB,STAT1 
Hepatic Fibrosis / Hepatic Stellate Cell Activation 1,69E00 CXCL8,STAT1 
Agranulocyte Adhesion and Diapedesis 1,66E00 CXCL8,CCL23 
Tryptophan Degradation III (Eukaryotic) 1,6E00 IDO1 
IL-22 Signaling 1,54E00 STAT1 
Role of JAK1, JAK2 and TYK2 in Interferon Signaling 1,54E00 STAT1 
IL-17A Signaling in Gastric Cells 1,52E00 CXCL8 
Role of JAK family kinases in IL-6-type Cytokine Signaling 1,52E00 STAT1 
IL-15 Production 1,49E00 STAT1 
IL-9 Signaling 1,39E00 STAT1 
Role of JAK2 in Hormone-like Cytokine Signaling 1,39E00 STAT1 
Interferon Signaling 1,37E00 STAT1 
Autophagy 1,37E00 MAP1LC3A 
Glucocorticoid Receptor Signaling 1,36E00 CXCL8,STAT1 
Role of PKR in Interferon Induction and Antiviral Response 1,32E00 STAT1 
Role of Hypercytokinemia/hyperchemokinemia in the Pathogenesis of Influenza 1,29E00 CXCL8 
Role of IL-17F in Allergic Inflammatory Airway Diseases 1,28E00 CXCL8 
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iNOS Signaling 1,28E00 STAT1 
Hematopoiesis from Pluripotent Stem Cells 1,26E00 CXCL8 
CNTF Signaling 1,21E00 STAT1 
Role of Cytokines in Mediating Communication between Immune Cells 1,2E00 CXCL8 
Role of IL-17A in Arthritis 1,2E00 CXCL8 
Thrombopoietin Signaling 1,19E00 STAT1 
EGF Signaling 1,18E00 STAT1 
Activation of IRF by Cytosolic Pattern Recognition Receptors 1,14E00 STAT1 
Role of JAK1 and JAK3 in γc Cytokine Signaling 1,14E00 STAT1 
GM-CSF Signaling 1,14E00 STAT1 
IL-15 Signaling 1,13E00 CXCL8 
Growth Hormone Signaling 1,09E00 STAT1 
Caveolar-mediated Endocytosis Signaling 1,08E00 ALB 
IL-3 Signaling 1,08E00 STAT1 
T Helper Cell Differentiation 1,08E00 STAT1 
IL-17 Signaling 1,08E00 CXCL8 
JAK/Stat Signaling 1,08E00 STAT1 
Prolactin Signaling 1,07E00 STAT1 
FLT3 Signaling in Hematopoietic Progenitor Cells 1,07E00 STAT1 
TREM1 Signaling 1,06E00 CXCL8 
PDGF Signaling 1,05E00 STAT1 
Role of BRCA1 in DNA Damage Response 1,04E00 STAT1 
Bladder Cancer Signaling 9,99E-01 CXCL8 
UVA-Induced MAPK Signaling 9,94E-01 STAT1 
Communication between Innate and Adaptive Immune Cells 9,89E-01 CXCL8 
Pancreatic Adenocarcinoma Signaling 9,18E-01 STAT1 
Fc Epsilon RI Signaling 9,1E-01 FCER1A 
Renin-Angiotensin Signaling 9,06E-01 STAT1 
phagosome formation 9,06E-01 FCER1A 
Type I Diabetes Mellitus Signaling 9,02E-01 STAT1 
Role of Tissue Factor in Cancer 9,02E-01 CXCL8 
p38 MAPK Signaling 8,77E-01 STAT1 
HMGB1 Signaling 8,67E-01 CXCL8 
LXR/RXR Activation 8,64E-01 ALB 
Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses 8,51E-01 CXCL8 
FXR/RXR Activation 8,47E-01 ALB 
Hepatic Cholestasis 7,5E-01 CXCL8 
Acute Phase Response Signaling 7,3E-01 ALB 
Role of NFAT in Regulation of the Immune Response 7,26E-01 FCER1A 
Dendritic Cell Maturation 7,12E-01 STAT1 
IL-8 Signaling 6,97E-01 CXCL8 
Clathrin-mediated Endocytosis Signaling 6,95E-01 ALB 
ERK/MAPK Signaling 6,91E-01 STAT1 
Systemic Lupus Erythematosus Signaling 6,39E-01 RNU11 
Colorectal Cancer Metastasis Signaling 6,02E-01 STAT1 
Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis 5,18E-01 CXCL8 
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Finally, the immunomodulatory impact of BmA treatment before LPS re-stimulation on canonical 
pathways was investigated (BmA+LPS vs. LPS, Tab. 7). Granulocyte and agranulocyte adhesion 
and diapedesis (both CXCL5, CXCL6, CXCL7, CCL20, PECAM1, and MMP9), IL-17A in 
psoriasis, arthritis and in airway cells (all CCL20, CXCL5, and CXCL6) and LXR/RXR activation 
(ALB, CD14 and MMP9) were identified. Associations to IL-17-driven diseases including the role 
of IL-17F in allergic inflammatory airway diseases (CXCL5, CXCL6), IL-17A signaling in gastric 
cells (CCL20) and IL-17A signaling in fibroblasts were found beside IL-17 signaling (CXCL5). Of 
notice, at least 2 gene associations to atherosclerosis signaling (ALB, MMP9) and hepatic fibrosis 
(CD14, MMP9) were identified.  
Table 7: Ingenuity Canonical Pathways® analysis of differentially expressed genes of human monocytes that were BmA treated 
and LPS re-stimulated (BmA+LPS vs. LPS). List of pathways, P value and identified molecules are displayed. 
Ingenuity Canonical Pathways -log(P value) Molecules 
Granulocyte Adhesion and Diapedesis 6,74E00 CXCL5,CXCL6,CXCL7,CCL20, 
PECAM1, MMP9 
Agranulocyte Adhesion and Diapedesis 6,57E00 CXCL5,CXCL6,CXCL7,CCL20, 
PECAM1, MMP9 
Role of IL-17A in Psoriasis 6,1E00 CCL20,CXCL5,CXCL6 
Role of IL-17A in Arthritis 4,18E00 CCL20,CXCL5,CXCL6 
IL-17A Signaling in Airway Cells 3,96E00 CCL20,CXCL5,CXCL6 
LXR/RXR Activation 3,15E00 ALB,CD14,MMP9 
Role of IL-17F in Allergic Inflammatory Airway Diseases 2,73E00 CXCL5,CXCL6 
Airway Pathology in Chronic Obstructive Pulmonary Disease 1,94E00 MMP9 
Atherosclerosis Signaling 1,85E00 ALB,MMP9 
Leukotriene Biosynthesis 1,67E00 LTA4H 
Hepatic Fibrosis / Hepatic Stellate Cell Activation 1,54E00 CD14,MMP9 
Leukocyte Extravasation Signaling 1,48E00 PECAM1,MMP9 
IL-17A Signaling in Gastric Cells 1,45E00 CCL20 
MIF-mediated Glucocorticoid Regulation 1,33E00 CD14 
Inhibition of Angiogenesis by TSP1 1,32E00 MMP9 
Cell Cycle Regulation by BTG Family Proteins 1,3E00 NOCT 
IL-17A Signaling in Fibroblasts 1,3E00 CXCL5 
Inhibition of Matrix Metalloproteases 1,26E00 MMP9 
Neuroprotective Role of THOP1 in Alzheimer's Disease 1,25E00 MMP9 
MIF Regulation of Innate Immunity 1,24E00 CD14 
iNOS Signaling 1,21E00 CD14 
Glioma Invasiveness Signaling 1,1E00 MMP9 
Eicosanoid Signaling 1,05E00 LTA4H 
IL-10 Signaling 1,03E00 CD14 
GDNF Family Ligand-Receptor Interactions 1,03E00 PDLIM7 
Macropinocytosis Signaling 1,03E00 CD14 
Caveolar-mediated Endocytosis Signaling 1,01E00 ALB 
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IL-17 Signaling 1,00E+00 CXCL5 
LPS-stimulated MAPK Signaling 9,96E-01 CD14 
Toll-like Receptor Signaling 9,9E-01 CD14 
VDR/RXR Activation 9,69E-01 CD14 
Bladder Cancer Signaling 9,24E-01 MMP9 
Death Receptor Signaling 9,01E-01 TNFRSF21 
Axonal Guidance Signaling 8,83E-01 ADAM19,MMP9 
HIF1α Signaling 8,59E-01 MMP9 
Pancreatic Adenocarcinoma Signaling 8,44E-01 MMP9 
IL-6 Signaling 8,08E-01 CD14 
Role of Pattern Recognition Receptors in Recognition of Bacteria and 
Viruses 
7,78E-01 PTX3 
FXR/RXR Activation 7,75E-01 ALB 
Ovarian Cancer Signaling 7,59E-01 MMP9 
IL-12 Signaling and Production in Macrophages 7,53E-01 ALB 
Adipogenesis pathway 7,5E-01 NOCT 
Relaxin Signaling 7,47E-01 MMP9 
Tec Kinase Signaling 6,88E-01 TNFRSF21 
Hepatic Cholestasis 6,79E-01 CD14 
Acute Phase Response Signaling 6,6E-01 ALB 
Production of Nitric Oxide and Reactive Oxygen Species in 
Macrophages 
6,36E-01 ALB 
IL-8 Signaling 6,27E-01 MMP9 
Regulation of the Epithelial-Mesenchymal Transition Pathway 6,27E-01 MMP9 
Clathrin-mediated Endocytosis Signaling 6,25E-01 ALB 
ILK Signaling 6,25E-01 MMP9 
Systemic Lupus Erythematosus Signaling 5,71E-01 RNU11 
Actin Cytoskeleton Signaling 5,67E-01 CD14 
LPS/IL-1 Mediated Inhibition of RXR Function 5,6E-01 CD14 
Colorectal Cancer Metastasis Signaling 5,34E-01 MMP9 
 
Moreover, the ten highest differentially expressed genes that were affected by BmA priming 
before LPS stimulation were further analyzed by IPA® analysis to determine the common 
superordinate affected function in vivo (BmA+LPS vs. LPS). All identified top transcripts CD14, 
TNFRSF21, PECAM-1, ALB, MMP9, CCL20, CXCL5, CXCL6, CXCL7, and PTX3 were related to 
cell movement of myeloid cells (Fig. 24). 
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Figure 24: BmA treatment before LPS stimulation affects cell movement of myeloid cells. Analysis of top 10 differentially 
expressed genes of BmA primed LPS re-stimulated compared to LPS-only stimulated monocytes (BmA+LPS vs. LPS) revealed 
interrelation to cell movement of myeloid cells and impact on associated canonical pathways (FC ≥ 1.5 and P value < 0.05). 
Upregulated differentially expressed genes are indicated in red and downregulated genes in green. 
 
In summary, BmA treatment before LPS stimulation compared to LPS alone resulted in several 
differentially expressed genes that were enriched in canonical pathways like granulocyte and 
agranulocyte adhesion, diapedesis and atherosclerosis. Furthermore, the IPA® analysis revealed 
associations to several IL-17-dependent pathways and diseases including arthritis, psoriasis and 
allergic inflammatory airway diseases. The BmA treatment showed evidence for the 
immunomodulatory effect of filarial extracts on human non-endemic monocyte responses with 
and without subsequent pro-inflammatory stimulation. Consequently, our results revealed 
transcripts and associated pathways that may be involved in the development of filaria-caused 
pathology and dysregulated immune responses as they occur e.g. during autoimmunity. 
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Discussion 
 
Despite constant efforts in intensive care units (ICU), severe sepsis and septic shock remain a 
leading cause of hospital mortality worldwide (Beale et al., 2009). The SepNet Critical Care Trials 
Group identified a 40.4% mortality rate of patients with severe sepsis or septic shock in German 
ICUs (SepNet Critical Care Trials, 2016). Novel classifications (SEPSIS-3) of septic shock 
patients even increase this number to a mortality of 50%. A strongly increased number of 
hospitalizations for severe sepsis patients were determined in the United States between 2003 
and 2007, however with a reduction in mortality (Lagu et al., 2012; Suarez De La Rica et al., 
2016). Hence, improved sepsis treatments are needed.  
Eosinophils play a pivotal role in clearance of helminth infections and the development of allergy, 
but the clinical relevance of eosinopenia during sepsis is controversially debated, in part due to 
the lack of experimental data (Shaaban et al., 2010; Smithson et al., 2009). Previously we showed 
that an experimental L. sigmodontis infection protects against E. coli-induced sepsis by leading 
to a milder hypothermia, improving bacterial clearance and reducing systemic inflammation 
without worsening immune paralysis (Buerfent et al., 2015; Gondorf et al., 2015). Hence, the first 
objective of this thesis was to determine eosinophil responses against bacterial pathogens and 
the impact of eosinophils on the outcome of sepsis in the mouse model. A locus and filarial-
infection dependent transcriptome profiling of eosinophils was performed in the absence or 
presence of an E. coli challenge.  
As a second objective, the immunomodulatory properties of a crude filarial extract of the human 
pathogenic filaria Brugia malayi on subsequent LPS E. coli-induced responses were investigated. 
A transcriptome-wide expression analysis and subsequent pathway analysis of stimulated human 
monocytes from non-endemic healthy male volunteers was performed. Identified transcripts may 
be candidates that are involved in the development of filarial pathology. Moreover, the pathway 
analysis may reveal bystander immune responses that affect autoimmune diseases. 
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4.1 Eosinophil granulocytes are involved in the protection against sepsis  
 
4.1.1 Eosinophil-deficiency exacerbates inflammation during E. coli-induced sepsis 
 
Using a well-accepted animal model for clinical sepsis (Hubbard et al., 2005), the lack of 
eosinophils in ∆dblGATA mice significantly increased the hypothermia four to six hours after the 
E. coli challenge compared to WT BALB/c controls. In addition, levels of systemic pro-
inflammatory mediators were increased and the numbers of adaptive und innate immune cells 
were reduced in ∆dblGATA mice six hours after the E. coli injection. This was accompanied by 
an increased peritoneal bacterial load in ∆dblGATA mice (p=0.0575). Thus, our results propose 
that eosinophils are involved during inflammatory responses against pathogens and the outcome 
of sepsis. In agreement to this, an increased bacterial load was observed 18 h after the induction 
of Pseudomonas aeruginosa-induced peritonitis in PHIL mice, a mouse line lacking eosinophil-
promyelocytes (Lee et al., 2004; Linch et al., 2009). However, the Pseudomonas aeruginosa 
infection led to unaltered systemic levels of pro- and anti-inflammatory cytokines. The discrepancy 
between this study and the results of my thesis could be due to the differences in the timing of 
the analysis, as well as to the pathogen investigated. An overexpression of IL-5 in transgenic 
NJ.1638 mice also exhibited an improved sepsis outcome, which was nevertheless independent 
of eosinophils (Linch et al., 2012). This suggests that bystander immune responses induced by 
IL-5 overexpression may compensate for the lack of mature eosinophils as the IL-5 receptor is 
present on other immune cells like B cells (Hitoshi et al., 1990). During parasite infection, IL-5 is 
mainly produced by CD4+ helper T cells promoting eosinophilia for parasite clearance (Cadman 
et al., 2014; Lee et al., 1997). In addition, Specht et al. previously demonstrated that eosinophil 
peroxidase (EPO) and major basic protein (MBO) are essential for the defense against 
experimental L. sigmodontis infections (Specht et al., 2006). Furthermore, a MBP deficiency 
altered the IL-10 production of thoracic macrophages, whereas an EPO-deficiency-induced 
eosinophilia was based on increased IL-5 levels derived from CD4+ T cells that both may 
compensate for the impaired anti-filarial defense. Future studies should therefore further decipher 
to which degree eosinophils and IL-5 are implemented in protective immune responses during 
sepsis. Moreover, eosinophils are important for gut immune homeostasis because eosinophils 
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promote the TGF-dependent development of mucosal IgA producing plasma cells in the Peyer’s 
patches (Chu et al., 2014). Chu et al. also presented evidence for eosinophil-derived IL-6 and 
APRIL production in bone marrow to promote plasma cell maintenance (Chu et al., 2011). In 
addition, the lack of eosinophils diminishes the numbers of regulatory T cells and dendritic cells 
that contributes to changes of the microbiota composition in the gut lumen. Generally, the 
absence of eosinophils induces IgG1 producing plasma cells in the Peyer’s patches that are 
associated with an affected control of microorganisms and inflammation. Thus, previous 
publications and the results of this thesis suggest that eosinophil granulocytes exhibit various 
regulatory functions and are involved in the control of local inflammatory responses like gut 
homeostasis or pathogen-induced inflammation as it occurs during bacterial-induced peritonitis 
and respiratory viral infection (Percopo et al., 2014).  
 
4.1.2 Eosinophils release pro-inflammatory recruitment factors to TLR2 and TLR4 ligands 
 
Not only can eosinophils reduce the bacterial burden in vitro via the spontaneous release of 
mitochondrial DNA and eosinophil granule proteins like the eosinophil cationic protein (ECP) 
forming bactericidal extracellular networks (Pulido et al., 2012; Yousefi et al., 2008), but also 
release chemokines like CXCL1 (KC) and CCL5 (RANTES) as well as cytokines IL-4 and IL-6 
after exposure to bacterial-pathogen patterns, which may essentially modulate granulocyte 
recruitment and the local cytokine milieu. In the murine asthma model, lipopolysaccharide was 
previously shown to induce eosinophil migration (Penido et al., 2001). Penido et al. demonstrated 
that eosinophil accumulation after LPS injection is independent of eotaxin and CCL5 but 
dependent on CCR3. Purified human eosinophils also express the CD14 co-receptors TLR2 and 
TLR4 and a stimulation with LPS resulted in a dose-dependent release of ECP and TNF (Plötz et 
al., 2001). Furthermore, LPS in presence of IL-5 and IL-33 was shown to induce IL-4 and IL-13 
responses of bmEos and that autocrine granulocyte macrophage colony-stimulating factor (GM-
CSF) production mediates eosinophil survival (Willebrand and Voehringer, 2016).  
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The results of this thesis indicate that a stimulation of bmEos with the TLR4-ligand E. coli LPS 
ultrapure or the TLR1/2-ligand Pam3CSK4 induces a substantial CXCL1 and CCL5 response that 
is known to be chemotactic for neutrophils, monocytes, T cells and eosinophils, respectively. 
Moreover, the exposure to LPS resulted in a strong increase of IL-6 levels (Hunter and Jones, 
2015). Pre-exposure to CCL11 and CCL24 did not affect the increased release of CCL5 and IL-6 
but CXCL1, which may suggest a specific role in neutrophil recruitment. Elevated levels of IL-6 
were previously associated with severe cases of sepsis and septic shock (Hack et al., 1989). 
Accordingly, sepsis induced development of hypothermia was worsened in IL-6 deficient mice 
(Remick et al., 2005). The application of anti-IL-6 antibodies, which impair neutrophil recruitment, 
in B10/D2 nsnJ mice results in a reduced expression of the complement factor 5a receptor and 
an improved sepsis outcome (Riedemann et al., 2003b). Similarly, reduce serum IL-6 levels and 
improved sepsis outcome were observed in chronic L. sigmodontis infected BALB/c mice 
(Gondorf et al., 2015). Since eosinophils release various chemoattractants like CXCL1 and IL-6 
in response to TLR1/2 and TLR4 stimulation, eosinophils may promote neutrophil recruitment and 
activation to improve early anti-bacterial responses during sepsis (Fielding et al., 2008; Sawant 
et al., 2016). Platelet-derived CCL5 was moreover previously described to promote neutrophil 
recruitment in experimental colitis and septical lung injury (Hwaiz et al., 2015; Yu et al., 2016). 
Thus, induced recruitment of neutrophils by increased levels of CCL5, CXCL1 and IL-6 of 
eosinophils may indicate an up to now unknown protective mechanism during the early phase of 
sepsis. Consequently, further studies should investigate whether altered levels of eosinophil-
derived neutrophil chemoattractants correlate with the severity of sepsis since early improved 
neutrophil recruitment in experimental sepsis was shown to improve bacterial clearance and thus 
sepsis survival (Craciun et al., 2010).  
The release of IL-4 by bmEos was enhanced by CCL24 pre-stimulation. Eosinophil-derived IL-4 
is known to promote local alternative activation of adipose tissue macrophages (Wu et al., 2011). 
Moreover, adipokine/myokine meteorin-like (Metrnl) was identified to trigger IL-4 and IL-13 
production by eosinophils (Rao et al., 2014) that leads to a catecholamine release of AAMs, 
promoting UCP1-expressing “beige” adipocytes (Lee and Tontonoz, 2014; Qiu et al., 2014).  
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Thus, CCL24 priming of eosinophils may have an essential impact on several eosinophil-derived 
IL-4 associated immune responses. Dixon et al. provided evidence for increased mRNA CCL24 
levels in gastrointestinal Trichinella spiralis and Trichuris muris infection (Dixon et al., 2006) and 
Zimmermann et al. additionally demonstrated that CCL24 expression is induced by IL-4 
overexpression in transgenic mice and after intranasal administration (Zimmermann et al., 2000). 
Accordingly, our results suggest that increased levels of CCL24 caused by filarial infection may 
additionally improve the induction of a regulatory Th2 response firstly during the chronic filarial 
infection and secondly during the early phase of sepsis. Although Lechner et al. demonstrated 
that CCL24 levels are not altered in humans during an occult O. volvulus infection (Lechner et al., 
2012), further studies should focus on the dependence of CCL24 and IL-4 levels and additionally 
they should determine whether a CCL24 deficiency or an overexpression correlate with an 
increased pathology in experimental filarial infection and further influence sepsis survival in filarial 
infected and sepsis protected mice.  
 
4.1.3 Eosinophils independently regulate CCR3 receptor and ICAM-1 expression 
 
Besides its role in cell adhesion, ICAM-1 is an important survival factor for eosinophils (Pazdrak 
et al., 2008). The CCR3 receptor binds eotaxin and is therefore required for eosinophil recruitment 
to the place of inflammation. Moreover, eosinophils detect pathogens via Toll-like-receptors 
TLR1, TLR2 and TLR4 and secrete mediators, thus mediating protection during sepsis. 
Kobayashi et al. and Czech et al. showed that the pro-inflammatory cytokine TNF released by 
human monocytes after LPS stimulation, results in the up-regulation of the intercellular adhesion 
molecule 1 (ICAM-1) on human eosinophils (Czech et al., 1993; Kobayashi et al., 2009). Since 
bmEos respond to the TLR2 ligand Pam3CSK4, eosinophils may respond to Wolbachia 
endosymbionts and hereby support anti-filarial responses (Nfon et al., 2006). The pre-treatment 
with CCL24 reduced the CCR3, but not the ICAM-1 expression, suggesting two independent 
mechanisms. CCR3-dependent recruitment of eosinophils via eotaxins was previously shown for 
Mycobacterium bovis BCG pleural infection in mice (D'Avila et al., 2007). Thus, we hypothesized 
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that in E. coli-induced sepsis eosinophils are recruited via chemoattractants like eotaxins, e.g. 
produced by inflammatory monocytes guided to the place of infection (Gentil et al., 2014; Travers 
and Rothenberg, 2015). The activation via TLR2/(TLR6), TLR4 or/and pro-inflammatory cytokines 
induces ICAM-1 expression, thus increasing the adherence and cross-talk to other leucocytes 
(Rothlein et al., 1986). In addition, the subsequent down-regulation of CCR3 by increased levels 
of CCL24 and hypothetically by CCL11 may lead to the local abidance of the recruited eosinophils. 
Increased eotaxins level generally induce chemotaxis of eosinophils and may accordingly induce 
the remaining of eosinophils at the place of inflammation. Thus, the induction of ICAM-1 by 
pathogen recognition via TLR may improve cell-cell-communication and immigration into 
inflammatory tissue.  
 
4.1.4 Eosinophil granulocytes execute important roles during sepsis – a hypothesized model 
 
It can be hypothesized that eosinophil granulocytes are essentially involved in immune responses 
against gram-negative bacteria during sepsis. Not only can eosinophils reduce the bacterial 
burden in vitro, but their release of chemotactic mediators may help to recruit additional 
phagocytes. The results of this thesis showed that eosinophil-deficient mice had an increased 
peritoneal bacterial load during sepsis and reduced numbers of innate immune cells at the site of 
inflammation. Principally, E. coli-injections result in an excessive inflammatory response leading 
to systemic inflammation (Denk et al., 2012). However, depending on the pathogen load and 
virulence, the activation of leucocytes leads to a rapid pro-inflammatory response affecting 
antigen-presenting cells like dendritic cells and macrophages, but also neutrophils (Hotchkiss and 
Karl, 2003). Subsequently, CD4+ and CD8+ T cells are activated (Kasten et al., 2010a; Kasten 
et al., 2010b). The release of inflammatory products enhances the adaptive and innate cell 
recruitment to the place of inflammation, but also increases the likelihood for uncontrolled 
systemic inflammation that can lead to apoptosis, hypoxia, multiple organ failure and 
consequently death (Bosmann and Ward, 2013; Buras et al., 2005; Hotchkiss and Karl, 2003). 
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Hence, in our proposed sepsis model eosinophils may be guided by the release of increased 
levels of the CCR3 ligands and the presence of TLR ligands to the place of infection.  
Our initial transcriptional analysis of filariae-induced eosinophils further revealed an upregulation 
of interferon response-associated transcripts. Further analysis should determine whether chronic 
filarial infection also modulates the expression of TLRs and the impact of chemoattractants on 
TLR expression and parasite and bacterial clearance. Such a modulation by helminth infections 
was previously reported to impair anti-viral responses (Buerfent et al., 2015; Kroidl et al., 2016; 
Osborne et al., 2014).  
Furthermore, the down-regulation of CCR3 and increase of ICAM-1 may result in a cross-talk to 
leucocytes and remaining in inflammatory tissue. Local Th2 cell-derived or autocrine IL-5 may 
subsequently pro-long eosinophil survival and functionality. Subsequently, with the secretion of 
extracellular bactericidal structures eosinophils may not only reduce the bacterial burden, but 
additionally induce neutrophil influx by the release of chemokines. An early increased neutrophil 
influx was previously shown to improve bacterial clearance and survival (Craciun et al., 2010). 
Thus, development of eosinopenia may indeed be an unspecific marker for the severity of sepsis. 
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4.1.5 Outlook: Immunomodulatory impact of helminths on eosinophils  
In line with previous data from our group and others our recent results reveal that eosinophil 
granulocytes are essentially involved in pro-inflammatory immune diseases like sepsis, diabetes 
and cancer (Carretero et al., 2015; Wu et al., 2011). Further analysis should be based on our 
initial results of transcriptome-wide profiling of eosinophils and analyze the impact of eosinophil 
modulation in the context of a filarial infection and sepsis modulation. The proteins arginase-1, 
chitinase-like protein 3 and Resistin-like alpha were differentially expressed by experimental L. 
sigmodontis infection compared to eosinophils derived from the intestine of naïve mice and were 
previously associated with alternatively activated macrophages induced by nematode infection 
(Loke et al., 2000). Thus, further transcriptome-wide analysis may also determine different locus-
specific subtypes of eosinophil granulocytes that may have a specific role during parasitic and 
bacterial infection but also other eosinophil-associated diseases like allergy.   
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4.2 Genome-wide transcriptional profiling of human monocytes stimulated with filarial extract 
and LPS reveals link to IL-17 associated pathways and diseases  
 
Helminth and helminth-derived products modulate cellular functions of host immune cells. Filarial 
nematodes basically induce a regulatory Type 2 immune response that counter-regulates pro-
inflammatory Type 1 responses (Maizels and McSorley, 2016). Experimental filarial infections and 
filariae-derived products were shown to exhibit protective effects on inflammatory disorders. The 
experimental L. sigmodontis infection revealed protective effects on E. coli-induced sepsis by 
reducing inflammation during the SIRS phase without worsening the anti-inflammatory CARS 
phase and the risk of secondary infections (Buerfent et al., 2015; Gondorf et al., 2015). In addition, 
the L. sigmodontis infection and crude extract administration improves metabolic disorders like 
diabetes, hence autoimmune and diet-induced glucose intolerance (Ajendra et al., 2016a; Berbudi 
et al., 2016b; Hübner et al., 2012b; Hübner et al., 2009a). Furthermore, filariae-derived 
excretory/secretory products like ES-62 and analogues were shown to protect against 
inflammatory diseases like experimental atherosclerosis, systemic lupus erythematosus, 
rheumatoid arthritis and allergy (Aprahamian et al., 2015; Pineda et al., 2014; Rodgers et al., 
2015b; Rzepecka et al., 2014). The recombinant cystatin of the human filaria Brugia malayi 
(rBmCys) ameliorates experimental colitis in mice (Khatri et al., 2015a; Khatri et al., 2015b). 
Interestingly, in human lymphatic filarial disease, a severe pathology with clinical symptoms like 
lymphedema, hydrocele or elephantiasis develop in patients that fail to down-regulate such 
inflammatory responses (Babu and Nutman, 2012), whereas asymptomatic infected humans are 
associated with a strong immune tolerance against circulating microfilariae or circulating parasite 
antigens.  
Consequently, the immunomodulatory effect of the crude filarial extract of Brugia malayi (BmA) 
on purified human non-endemic male CD14+ monocytes was analyzed. 47.000 transcripts were 
analyzed and 49 differentially expressed transcripts were identified (FC≥1.5; p≤0.05) that are 
specific for immunomodulation by BmA pre-exposure to subsequent LPS ultrapure E. coli 
stimulation (BmA+LPS vs. LPS). Principally, the LPS stimulation alone resulted in 2.215 
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differentially expressed genes that are involved in inflammation, thus confirming recent findings 
(Kim et al., 2014). Since TLR4 signaling is essentially involved in autoimmune diseases, sepsis 
but also cancer, immunomodulation of LPS-driven responses by helminth products may affect 
bystander immune responses and autoimmunity as well (Rakoff-Nahoum and Medzhitov, 2009).  
The exposure of human monocytes to the crude B. malayi extract alone (BmA vs. control.) 
revealed 42 differentially expressed genes that were associated with inflammation, immune 
system diseases, chemokine signaling pathway, bronchial diseases and bronchiolitis. BmA pre-
exposure before LPS stimulation resulted in 49 differentially expressed genes compared to LPS-
only stimulated monocytes (BmA+LPS vs. LPS). In addition to the enriched pathways by BmA 
alone, the BmA pre-exposure before LPS stimulation resulted in differentially expressed genes 
that were linked to rheumatoid arthritis, respiratory tract infections, infarction and arteriosclerosis. 
 
4.2.1 BmA induces cellular protective mechanisms in human non-endemic monocytes  
 
The BmA treatment of monocytes of non-endemic donors induced the expression of several 
members of the metallothionein family, small nucleolar and nuclear RNAses and chemokines. 
Similarly, the BmA pre-treatment before LPS re-stimulation resulted in altered levels of the 
metallothioneins MT1F-H and MT1M. Metallothioneins (MTs) are small cysteine-rich proteins that 
are involved in the cellular detoxification as a consequence of elevated metal ion concentrations 
like zinc or cadmium (Suhy et al., 1999). Since MTs are principally induced in eukaryotic cells to 
prevent apoptosis, MTs were previously described as a cellular protective mechanism to reduce 
chemotherapy-induced apoptosis in acute leukemia patients and were discussed as potential 
reason for drug resistance and tumor development (Takahashi, 2012; Tsangaris et al., 2000). 
Moreover, in helminth infection an up-regulation of MT1 was described in regulatory CD4+CD25hi 
T cells in Schistosoma mansoni infection (Layland et al., 2010). The nematode Caenorhabditis 
elegans releases the stress-related metallothioneins CeMT-1 and CeMT-2 in presence of Zn (II) 
or Cd (II) (Roh et al., 2006; You et al., 1999; Zeitoun-Ghandour et al., 2010). Accordingly, our 
data suggest that the crude filarial extract BmA contains active immunomodulatory components 
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and reduces apoptosis in the absence of a LPS- re-stimulation. Such a reduced apoptosis was 
also observed in macrophages of L. sigmodontis-infected animals upon E. coli-challenge and 
during Heligmosomoides polygyrus infection (Doligalska et al., 2007; Gondorf et al., 2015). 
Further experiments should investigate the impact of metallothioneins during filarial infection, 
infection-associated diseases and bystander immune responses. Elevated levels of MT may be 
part of the induced protection in inflammatory disorders by supporting cell survival and 
functionality of regulatory cell populations, but may also lead to an increased risk for tumor growth 
and consequently carcinogenesis (Brindley et al., 2015; Oikonomopoulou et al., 2014). Herrera 
and Ostrosky-Wegman suggested that helminth-induced carcinogenesis may be promoted further 
by an inflammation-induced genetic instability, thus DNA damage and also epigenetic events 
(Herrera and Ostrosky-Wegman, 2001; Neeshma Jaiswal and Sandeep K, 2015). Furthermore, 
induced MTs may also be involved in the pathogenesis during filarial infection since 
metallothionein 2 (MT2) is an essential regulator of vascular endothelial growth factor (VEGFC) 
and thus angiogenic processes (Schuermann et al., 2015). In this line, Debrah et al. provided 
evidence that plasma VEGF-A and VEGF-A gene polymorphisms are associated with hydrocele 
development in lymphatic filariasis (Debrah et al., 2007).  
BmA pre-exposure before LPS re-stimulation elevated the levels of matrix metalloproteinases 9 
(MMP-9; Gelatinase B). MMP-9 alters the expression of VEGF in retinal pigment epithelial (RPE) 
cells under hypoxic conditions (Hollborn et al., 2007) and MMP-9 is acting as a zymogen and is 
involved in the breakdown of the extracellular matrix (Egeblad and Werb, 2002). MMP-9 synthesis 
by monocytes is induced by TNF and negatively regulated by TGF- (Vaday et al., 2001). 
Anuradha et al. provided evidence that MMPs are essentially involved in regulating tissue 
pathology of bancroftian filariasis with increased ratios of MMP-1/tissue inhibitor of 
metalloproteinases (TIMP)-4 and MMP-8/TIMP-4 (Anuradha et al., 2012). Furthermore, elevated 
levels of MMP-9 and VEGF are associated with angiogenesis and a progression of 
carcinogenesis like gastric carcinomas (Bergers et al., 2000; Zheng et al., 2006) and could be an 
association for cancer promotion. Thus, confirming previous findings, BmA induces cellular 
protective mechanism, but further experiments are needed to determine the regulatory character 
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of MT and MMP-9 in lymphatic filariasis, autoimmune diseases and apoptosis-dependent 
diseases like cancer.  
Moreover, BmA treatment prior to LPS stimulation resulted in a suppression of pentraxin-3 (PTX3) 
in non-endemic monocytes, a soluble pathogen recognition receptor that provides anti-microbial 
recognition to several pathogenic structures and is mainly found in the muscle tissue promoting 
regulation of inflammations (Alles et al., 1994; Garlanda et al., 2002; Garlanda et al., 2016; Introna 
et al., 1996). PTX3 can recognize LPS and it modulates the release of tissue factors (TF) in 
human monocytes that are involved in thrombogenesis and wound healing (Napoleone et al., 
2004). In addition, PTX3 activity is reduced in the presence of pro-inflammatory mediators like 
TNF or IL-1 PTX3 was identified by Bonavita et al. as an extrinsic oncosuppressor that is 
epigenetically repressed in human tumors such as malignant smooth muscle tumors and 
colorectal cancer and regulates complement activation by interacting with C1q affecting tumor 
cell recruitment (Bonavita et al., 2015). PTX3 repression therefore leads to an increased cancer-
related inflammation and promotes M2 macrophage recruitment and tumor growth. Interestingly, 
Brugia malayi-derived Calreticulin (BmCRT) similarly interacts with the first component C1q of the 
human host to prevent classical complement pathway activation that may reduce pathogen 
clearance and clearance of apoptotic-cells by antigen-presenting cells as was previously shown 
for tissue PTX3 (Baruah et al., 2006; Yadav et al., 2014). Consequently, PTX3 may be a target 
to improve parasite clearance and tissue homeostasis.  
 
4.2.2 BmA modulates noncoding RNA expression with diverse cellular functions 
 
BmA exposure to human non-endemic monocytes altered the gene expression of the small 
nucleolar RNA families SNOR C/D box, SNOR H/ACA box, small Cajal body-specific RNA 
SCARNA, as well as small nuclear RNA families like RNUs. SnoRNAs are 60 to 300 nucleotides 
long, localized in the nucleolus and the most abundant group of metabolically stable noncoding 
RNAs that regulate gene expression at the level of transcription (Matera et al., 2007). Basically, 
box C/D snoRNAs mediate methylation of 2’-hydoxyl groups and are involved e.g. in the site-
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specific ribose methylation and thus in the maturation of pre-ribosomal RNA. Box H/ACA 
snoRNAs conduct the conversion of uridine into pseudouridine that provide regulatory functions 
in the suppression of translation termination (Karijolich and Yu, 2011; Kiss-Laszlo et al., 1998). 
Moreover, snoRNAs also provide microRNA functionality in post-transcriptional gene silencing 
(Ender et al., 2008; He and Hannon, 2004). The transcriptome profiling after BmA pre-exposure 
and subsequent LPS stimulation reveals new regulatory post-transcriptional candidates that were 
not previously associated with filarial diseases. Associations to inflammatory disorders were 
previously shown for SNORD12 as a potential marker for breast cancer (Askarian-Amiri et al., 
2011). Furthermore, previous investigations provide evidence that the small nuclear RNA 
component of mitochondrial RNA processing endoribonuclease (RMRP) is related to 
carcinogenesis in gastric cancer, immunodeficiency and cartilage-hair hypoplasia (Ip et al., 2015; 
Ridanpaa et al., 2001; Shao et al., 2016). BmA pre-exposure modulates changes in the gene 
expression of the RNU4ATAC gene that were previously associated with the Roifman Syndrome, 
a rare genetic disease that causes dysgammaglobulinemia, skeletal dysplasia, developmental 
delay and retinal dystrophy (Merico et al., 2015; Roifman, 1999). Thus, immunomodulation by 
helminths and helminth products may have a profound impact on regulatory cell mechanisms. 
Consequently, further investigations should focus on the regulatory impact of long non-coding 
RNA in the context of etiopathogenesis because of their alterative influence on gene expression 
and post-transcriptional processes (Engreitz et al., 2016).  
 
4.2.3 BmA priming before LPS treatment affects chemotaxis and cell movement of myeloid cells  
 
As another consequence of BmA priming before LPS re-stimulation, an upregulation of the 
neutrophil CXC chemoattractants and activators CXCL5 (ENA-78), CXCL6 (GCP-2) and CXCL7 
(PPBP) (Turner et al., 2014) were detected. CCL20, also known as Macrophage Inflammatory 
Protein-3 (MIP3A), was downregulated. CXCL5-7 signal via CXC receptor 2 (CXCR2) and are 
pro-angiogenic. Thus, they may contribute to the development of lymphedema in lymphatic filarial 
diseases since MMP-9 was additionally elevated due to BmA priming before LPS re-stimulation 
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(Couto et al., 2011). CXCL5 is a potent neutrophil recruitment factor and is additionally associated 
with tumor growth and carcinogenesis (Zhou et al., 2012). Zhou et al. further demonstrated that 
an increased CXCL5 expression in hepatocellular carcinoma cells (HCC) promotes tumor growth 
and metastasis. Correspondingly, the hypoxia-inducible factor (HIF)-1 similarly promotes 
CXCL6 expression in HCC (Tian et al., 2014). Since an upregulation of CXCL6 through the 
tetraspanin (TSPAN) 12–-catenin pathway promotes cancer cell invasion and proliferation, 
reduced levels of CXCL6 beside TSPAN12 were recently discussed as effective therapeutic 
option against epithelial cancer progression and lung cancer (Otomo et al., 2014; Zhu et al., 
2006). Moreover, CXCL5 is associated with colorectal cancer progression and consequently 
presented as a predictive prognostic marker for survival (Kawamura et al., 2012). CXCL7 was 
shown to induce cell proliferation in lung, colon, kidney and bile duct cancer (Desurmont et al., 
2015; Grepin et al., 2014; Guo et al., 2017; Unver et al., 2015). Furthermore, CXCL5-induced 
neutrophil infiltration in the murine model of LPS-induced keratitis suggest that increased CXCL5 
expression may also contribute to the pathogenesis in onchocerciasis and promote vision loss 
(Lin et al., 2007). The expression of MMP7, Claudin-7 (CLDN7) and CXCL6 was also upregulated 
in human chronic schistosomiasis (Gobert et al., 2015). In contrast, Rousselle et al. revealed a 
protective role of CXCL5 in atherosclerosis by a regulation of macrophage foam cell formation, 
limiting the cholesterol content of macrophages. However, in experimental colitis-associated 
colorectal cancer (CAC), a Taenia crassiceps infection reduces the CXCR2 expression in colon 
tissue (Leon-Cabrera et al., 2014). Consequently, CXCR2 neutralization antibodies may inhibit 
proliferation and thus the progression of human cancer.  
Since BmA treatment and LPS re-stimulation alter the release of the CXCR2 ligands CXCL5, 
CXCL6 and CXCL7, further context-specific analyses are needed to investigate the impact of 
CXCR2-dependent pathways on the development of filariae-driven diseases. The impact of 
filariae infection on cancer is still unclear (Hall et al., 2001).  
BmA priming before LPS re-stimulation reduced the CCL20 expression. CCL20 was previously 
shown to be characteristically induced in human inflammatory bowel disease (Kaser et al., 2004) 
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and the experimental Trichuris muris infection revealed chemotactic properties for dendritic cells 
for the recruitment to the colonic mucosa for CCL20 in combination with CCL5 (Cruickshank et 
al., 2009).  
Immunomodulation by BmA did not only alter the chemotactic behavior of monocytes of human 
non-endemic donors, but also reduced the expression of cell surface proteins CD86 (B7-2) and 
Human Leukocyte Antigen - antigen D Related (HLA-DR). Changes in the expression of major 
histocompatibility complex 2 and the co-stimulator for T cell priming were observed and were in 
line with our previous results of filariae-modulated macrophages that mediated protection against 
E. coli-induced sepsis (Gondorf et al., 2015). The expression of CD86 and HLA-DR in BmA-
primed and LPS-restimulated monocytes compared to LPS alone was significantly reduced. 
Furthermore, BmA stimulation alone reduced the expression of the glycoprotein CAMPATH 1 
(CD52). CD52 is targeted by the pharmaceutical drug Alemtuzumab, a common treatment for 
multiple sclerosis, chronic lymphocytic leukemia, transplantation and rheumatoid arthritis (Coles 
et al., 2012; Cooles et al., 2016; Fiegl et al., 2014). Multiple lines of evidence suggest that 
helminths and their products can protect against autoimmune diseases. For instance Correale et 
al. and Fleming showed that helminths mediate protection against multiple sclerosis (Correale, 
2014; Correale and Farez, 2009; Fleming, 2013), but further investigations are needed to 
determine whether a CD52 downregulation is involved in this protective effect (Baker and Isaacs, 
2014). Interestingly, tumor necrosis factor receptor superfamily member (TNFRSF) 21, a surface 
receptor and induced by NF-B activation and known as death receptor (DR) 6, serves as a 
marker for adult sarcomas and was reduced by BmA priming, followed by LPS re-stimulation 
(Kasof et al., 2001; Yang et al., 2012). Further investigation should determine whether filarial 
antigens reduce sarcoma development based on TNFRSF21 reduction. Moreover, altered levels 
of chemoattractants in combination with the altered expressions of ALB, PECAM-1, TNFRSF21 
and CD14 are associated with cell movement of myeloid cells analyzed by Ingenuity Pathway 
Analysis (IPA®). 
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4.2.4 BmA priming before LPS re-stimulation reveals link to inflammatory disorders including IL-
17 dependent diseases 
 
The Ingenuity® Canonical Pathways Analysis of BmA-altered transcripts revealed several 
associations with inflammatory disorders, mainly IL-17-dependent diseases, cell adhesion and 
migration, as well as autoimmune diseases. Granulocyte and agranulocyte adhesion and 
diapedesis pathways were the mostly affected pathways with six altered genes CCL20, CXCL5, 
CXCL6, CXCL7, MMP9, and PECAM1 in BmA-primed and LPS-restimulated compared to LPS-
alone stimulated monocytes. Changes in the expression of CCL20, CXCL5 and CXCL6 were 
subsequently associated with IL-17 dependent diseases, in particular the role of IL-17A in 
psoriasis, arthritis and airway cells (CCL20, CXCL5 and CXCL6), the role of IL-17F in allergic 
inflammatory airway diseases (CXCL5 and CXCL6), IL-17A signaling in gastric cells (CCL20), 
and IL-17A signaling in fibroblasts and IL-17 signaling alone (CXCL5). Such a modulation of IL-
17 pathways was previously shown to be part of the helminth-mediated protection against 
autoimmune diseases and the failure to modulate these IL-17 pathways was correlated to filarial 
pathogenesis. Elliot et al. demonstrated that intestinal Heligmosomoides polygyrus infection 
suppresses mucosal IL-17 production and protects against intestinal inflammation in piroxicam-
induced colitis, a model for inflammatory bowel disease (Elliott et al., 2008). With regard to filarial 
pathology, filarial infected O. volvulus and B. malayi patients that developed a severe pathology 
like lymphedema or hyperreactive onchocerciasis revealed increased Th17 responses with 
reduced numbers of regulatory T cells (Babu et al., 2009a; Katawa et al., 2015). Furthermore, 
evidence was provided that the development of Th17 responses in filarial infections is mainly 
established by IL-1 and IL-23 and associated with pathogenesis in the case of schistosomiasis 
(Anuradha et al., 2014; Mbow et al., 2013; Shainheit et al., 2011). F. hepatica-derived molecules 
protease cathepsin L1 (rFhCL1) and sigma class glutathione transferase (rFhGST-si) were shown 
to induce suppressive dendritic cells that dampen Th17 cells (Dowling et al., 2010). Consequently, 
these studies suggest that IL-17-dependent mechanisms contribute to the development of severe 
pathologies of helminth infections. Further experiments on the particular role of CCL20, CXCL5 
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and CXCL5 during the pathogeneses in filarial infections have not been conducted yet. 
Angiogenic chemoattractants like CXCL5 regulate IL-17 production in arthritis and neutrophil 
homeostasis (Mei et al., 2012; Pickens et al., 2011). Consequently, the dampening of IL-17 
dependent pathways may counter-regulate inflammatory autoimmune disorders like rheumatoid 
arthritis and systemic lupus erythematosus, as was recently shown for filariae-infected patients 
(Panda and Das, 2017). Thus, further investigations should focus on the  immunomodulation of 
IL-17-dependent pathways by helminths and helminth-derived molecules, especially in 
autoimmune diseases and inflammatory disorders (Helmby, 2015).  
Moreover, with at least two altered genes the pathways of LXR/RXR activation (ALB, CD14 and 
MMP9), atherosclerosis signaling (ALB, MMP9), hepatic fibrosis / hepatic stellate cell activation 
(CD14, MMP9), leukocyte extravasation signaling (PECAM1, MMP9), and axonal guidance 
signaling (ADAM19, MMP9) were affected after BmA priming and LPS re-stimulation. Most of the 
BmA-affected pathways after BmA priming and LPS re-stimulation were also found after BmA-
only stimulation. However, genes of the Oncostatin M signaling (MT2A, CHI3L1 and STAT1) and 
IL-6 signaling (CXCL8 and TNFAIP6) were mostly specifically enriched in BmA-only stimulated 
monocytes compared to unstimulated controls. Oncostatin M signaling was shown to be a potent 
inducer of IL-33 in lung and liver epithelial cells and to be involved in the tumor growth of non-
malignant human breast epithelial cells (HBECs) (Arshad et al., 2015; Grant et al., 2001; Richards 
et al., 2016). Furthermore, Oncostatin M (OSM), a member of the IL-6/LIF cytokine family, induces 
IL-33 receptor (ST2) expression on CD4+ T cells (Arshad et al., 2015). This ST2 receptor is 
required for the splenic clearance of microfilariae from peripheral blood in L. sigmodontis 
infections (Ajendra et al., 2014). Thus, a variation in the OSM pathway may affect the transmission 
of filariae, but the role of OSM in helminth infection needs to be examined further. Langdon et al. 
provided evidence that OSM induces eotaxin expression in mouse lung fibroblasts and thus is 
involved in the eosinophil infiltration and may contribute, in combination with IL-17A, to 
inflammatory airway diseases (Kwofie et al., 2015; Langdon et al., 2003). Hence, our findings 
suggest that the modulation of the OSM pathway may affect the clearance of helminth infections.  
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Furthermore, since OSM promotes the dysfunction of the mucosal epithelial barrier, OSM may 
also have an impact on the development of eosinophil-dependent diseases (Pothoven et al., 
2015). Thus, the modulation of OSM pathways may modify inflammatory responses like allergies.  
BmA treatment is also associated with IL-6 signaling. Confirming our results, Smith et al. provided 
evidence that IL-6 counter-balances Th2 responses, induces regulatory T cells and thus promotes 
host susceptibility to helminth infection in mice (Smith and Maizels, 2014). Thus, the modulation 
of IL-6 pathways by filariae may be an essential host response, but the pathogenic character of 
CXCL8 and TNFAIP6 that were enriched in altered IL-6 signaling has to be analyzed further.  
Our genome-wide transcriptional analysis of BmA-primed and LPS-restimulated human non-
endemic monocytes reveals associations to granulocyte and agranulocyte adhesion and 
diapedesis, atherosclerosis and several IL-17-dependent inflammatory pathways and diseases 
like psoriasis, arthritis and allergic inflammatory airway diseases. Moreover, BmA treatment 
before subsequent LPS re-stimulation resulted in a reduced MHC2 expression, suggesting a 
diminished antigen presentation and a lower expression of the co-stimulatory molecule CD86 that 
may contribute to a modulated cell movement and an expression of angiogenic chemoattractants. 
BmA-only treatment may also affect IL-6-dependent host-protective mechanisms. The 
immunomodulation of human non-endemic monocytes by helminths and helminth products may 
subsequently influence autoimmunity and inflammatory disorders. Thus, immunomodulation is 
not limited to disease-specific immune responses but may also affect bystander immune 
responses. 
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4.2.5 Expression quantitative trait loci (e²QTLs) analysis of human monocytes to determine DNA 
variations that contribute to different gene expressions of anti-filarial responses and helminth-
induced immunomodulation  
 
Figure 25: e²QTL analysis to determine regulatory gene variants that may be linked to the development of filarial pathology. 
Illustrations are taken from Servier Medical Arts (http://servier.com/Powerpoint-image-bank; June 28, 2017). 
The genome-wide transcriptional analysis of human non-endemic monocytes stimulated with the 
adult worm extract of Brugia malayi and subsequently with LPS revealed a link to several IL-17 
associated pathways and diseases as well as dysregulated immune responses that may lead to 
metabolic diseases like atherosclerosis. Using an e²QTL approach, genetic variants will be 
correlated in future analyses with the quantitative strength of transcript expression (Fig. 25). This 
will allow the identification of transcripts that are differentially expressed between individuals due 
to regulatory gene variants. Associations of single nucleotide polymorphisms (SNPs) will be 
further aligned with the transcriptome of human monocytes stimulated with BmA. Accordingly, 
genetic variants and new pathways may be identified that could be linked to the development of 
filarial pathology and present new treatment targets for filariasis. Understanding the underlying 
genetic mechanisms associated with differential expression after an antigenic stimulation of 
monocytes may also lead to new strategies for treating diseases that result from uncontrolled pro-
inflammatory responses like autoimmune diseases.  
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Helminth-mediated protection against E. coli-induced sepsis is independent of TGF 
 
Since helminth and helminth-derived products induce a regulatory anti-inflammatory milieu in their 
hosts, it was investigated whether the L. sigmodontis-mediated protection against E. coli-induced 
sepsis during the SIRS phase is dependent on the transforming growth factor (TGF) . TGF is 
induced during the CARS phase of sepsis and by chronic filarial infection (Buerfent et al., 2015; 
Ince et al., 2009). Moreover, Hübner et al. provided evidence that TGF is essential for the L. 
sigmodontis-mediated protection against type 1 diabetes (Hübner et al., 2012b). TGF includes 
three isoforms and is mainly produced by myeloid-derived cells, platelets and suppressive 
regulatory T cells and contributes to an immunosuppressive milieu (Borish and Steinke, 2003; 
Chen et al., 2001). Thus, systemic TGF1-3 was depleted in chronic L. sigmodontis-infected 
female BALB/cJ mice and uninfected age-matched controls by an intraperitoneal injection of 
100µg/mouse depletion antibody (Clone: 1D11.16.8) on day -3 and -1 before the injection of 
8.5x108 CFU E. coli K12. Controls were administered by 100µg/mouse IgG1 isotype control 
(Clone: MOPC-21, both BioXCell, West Lebanon, USA). 
TGF depletion does not alter L. sigmodontis improvement of E. coli-induced hypothermia, 
reduced peritoneal bacterial load and increased myeloid cell composition six hours after E. coli 
challenge
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Figure 26: L. sigmodontis induced protection against E. coli-induced sepsis is independent of TGF depletion during the SIRS 
phase. (A) Kinetic of the body temperature for six hours after intraperitoneal injection of 8.5x108 cfu E. coli K12 in chronic L. 
sigmodontis (L.s.)-infected BALB/c mice (L.s. Isotype: n = 20; L.s. TGF: n=20) and uninfected controls (Isotype: n = 18; TGF: 
n=17; significant differences were shows as: * = BALB/c + Isotype vs. BALB/c L.s. + Isotype, + = BALB/c + Isotype vs. BALB/c L.s. + 
TGF, # = BALB/c L.s. + Isotype vs. BALB/c + TGF and § = BALB/c + TGF and BALB/c L.s. + TGF). (B) Peritoneal bacterial 
load [cfu], (C) absolute cell number of CD11b+F4/80+ cells as well as (D) the RELM and (E) CD86 expression (mean fluorescence 
intensity) on CD11b+F4/80+ cells six hours after E. coli injection. (F) Serum cytokine/chemokine and (G) peritoneal 
cytokine/chemokine profile six hours after E. coli injection. Pooled data of three independent experiments with at least 6 mice per 
group. Data is shown as median or mean ± SEM and was tested for statistical significance by 2-way ANOVA and Bonferroni post 
hoc test (A, F+G) and 1-way ANOVA followed by Kruskal-Wallis test and Dunn's Multiple Comparison post hoc test (B-E). 
Significance is indicated as *p<0.05; **p<0.01; ***p<0.001 (B-G). 
 
The L. sigmodontis infection resulted in a reduced E. coli-induced hypothermia, which confirmed 
our previous findings (Fig. 26A+B) (Gondorf et al. 2015). Generally, the E. coli-only induced 
hypothermia was highly correlated with an increased peritoneal bacterial load (rs= -0.7074; p< 
0.0001; n=74 pooled individuals of three independent experiments). The reduced hypothermia in 
L. sigmodontis infected mice was further correlated with a reduced bacterial load. Importantly, 
TGF depletion did not influence the L. sigmodontis improved body temperature and reduced 
bacterial load. Moreover, the experimental L. sigmodontis infection led to significantly altered 
absolute and relative numbers of peritoneal macrophages, but not to an altered RELM 
expression (Fig. 26C+D). The CD86 expression was by tendency reduced but unaffected by 
TGF depletion (Fig. 26E).  
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Figure 27: The increased peritoneal numbers of monocytes, neutrophil and eosinophil granulocytes six hours after i.p. E. coli 
injection in chronic L. sigmodontis-infected BALB/c mice is not altered by anti-TGFβ treatment. (A+B) Relative and absolute 
number of peritoneal CD11b+Ly6G-Ly6C++ cells (monocytes), (C+D) CD11b+Ly6G+Ly6C+ cells (neutrophils) and 
CD11b+F4/80(med)SiglecF+ (eosinophils) (E+F) six hours after E. coli injection. Data represent three pooled independent 
experiments with at least six mice per group. Data are shown as median and was tested for statistical significance by Kruskal-
Wallis test followed by Dunn's Multiple Comparison post hoc test (*p<0.05; **p<0.01; ***p<0.001). 
 
No changes in systemic and peritoneal cytokine and chemokine levels of L. sigmodontis-infected 
animals six hours after E. coli challenge 
Since our previous findings provided evidence that a chronic filarial infection reduces the E. coli-
induced release of pro-inflammatory mediators like pro-inflammatory IL-6, the cytokine and 
chemokine profile was analyzed six hours after the E. coli injection (Gondorf et al., 2015). 
Confirming previous results, the L. sigmodontis-infected animals had lower concentrations of pro-
inflammatory cytokines/chemokines following the E. coli challenge compared to E. coli-injected 
controls (Fig. 26F+G). Interestingly, while almost no changes were observed with regard to IL-10 
and IFN production, the concentration of CXCL1 and CXCL2 was significantly reduced in L. 
sigmodontis-infected animals independent of previous TGF depletion. In L. sigmodontis-
uninfected controls the TGF depletion led to a trend in reduced peritoneal and serum TNF levels. 
TGF depletion does not alter increased numbers of monocytes, neutrophils and eosinophils 
caused by L. sigmodontis infection and six hours after E. coli injection 
L. sigmodontis increased the numbers of monocytes, neutrophil and eosinophil granulocytes six 
hours after the E. coli challenge compared to E. coli-only challenged controls (Fig. 27). 
Subsequently, TGF depletion did not affect the capacity of the L. sigmodontis infection to 
improve sepsis outcome and sepsis-relevant cell populations were not affected by the absence 
of TGF during the early phase of sepsis either.  
Accordingly, our results suggest that TGF is not essential for the L. sigmodontis-mediated 
protective effect during the initial SIRS phase of sepsis. Previous results of Ahmad et al. provided 
evidence that elevated levels of TGF are found one day after induced sepsis (Ahmad et al., 
1997). TGF is also known to induce TGF-induced proteins (TGFIp), an integrin-interacting 
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extracellular matrix protein that is associated with an increased vascular inflammation and thus 
with the severity of the sepsis (Bae et al., 2014). Regulatory T cells are described to produce 
TGF and also IL-10 to counter-regulate pro-inflammatory responses to pathogens and hence 
contribute to immunosuppression and an increased risk for secondary infections (Monneret et al., 
2003; Wisnoski et al., 2007). Moreover, Hiraki et al. demonstrated that the depletion of both TGF 
and IL-10 can reduce suppressive T cell populations and improve sepsis survival in mice (Hiraki 
et al., 2012). Since the TGF depletion did not impair the L. sigmodontis-mediated improved 
sepsis outcome, our results suggest that the filariae-mediated protection against sepsis is not 
dependent of counter-regulatory TGF levels. Our previous work revealed that L. sigmodontis 
modulated macrophages are essential in the protection against E. coli induced sepsis. We here 
demonstrate that the protective mechanism is independent of TGF despite helminth induced 
regulatory T cells and increased levels of peripheral TGF (Dittrich et al., 2008). Furthermore, 
during the compensatory CARS phase a chronic L. sigmodontis infection did not enhance TGF 
production and had no negative impact on sepsis outcome (Buerfent et al., 2015). In contrast to 
those results, the L. sigmodontis-mediated protection against autoimmune diabetes was 
dependent on TGF (Hübner et al. 2012). Consequently, our results suggest that dependent of 
the local context, several mechanisms of filarial immunomodulation may protect against 
inflammatory diseases (Helmby, 2015; Maizels and McSorley, 2016).  
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Transcriptome-wide analysis of human monocytes stimulated with Porphyromonas 
gingivalis LPS and metal ions and its impact on systemic and autoimmune diseases  
 
In cooperation with the Institute of Human Genetics (Prof. Dr. Markus M. Nöthen and PD Dr. 
Johannes Schumacher) and the Department of Orthodontics of the University of Bonn (Prof. Dr. 
Andreas Jäger and PD Dr. Lina Gölz) we conducted studies about the impact of LPS from the 
periodontopathogen Porphyromonas gingivalis (P.g.), nickel and cobalt metal ions on human 
monocytes. A genome-wide transcriptional analysis and an IPA® analysis was performed to 
further determine differentially expressed transcripts and pathways that are linked to periodontal 
destruction and systemic and autoimmune diseases. The transcriptome-analysis of LPS P.g. 
revealed 902 transcripts with several new candidates that are linked to autoimmune diseases like 
atherosclerosis, arthritis and cancer (Gölz et al., 2016a). The stimulation of human monocytes by 
nickel ions (Ni2+), signaling via cross-linking of two TLR4 monomers (imidazole groups) 
(Rothenberg, 2010), resulted in a total of 1385 differentially expressed transcripts in a dose-
dependent manner (Gölz et al., 2016b). The IPA® analysis of nickel-stimulated human monocytes 
revealed associations to colitis, cancer and encephalitis. Two publications with co-authorships in 
renowned peer-reviewed journals resulted out of those studies so far. These studies are the basis 
for future e²QTL analysis. 
Gölz L, Buerfent BC, Hofmann A, Rühl H, Fricker N, Stamminger W, Oldenburg J, Deschner J, 
Hoerauf A, Nöthen MM, Schumacher J, Hübner MP, Jäger A. Genome-wide transcriptome 
induced by nickel in human monocytes. Acta Biomater. 2016 Oct 1; 43:369-82.  
 
Gölz L, Buerfent BC, Hofmann A, Hübner MP, Rühl H, Fricker N, Schmidt D, Johannes O, Jepsen 
S, Deschner J, Hoerauf A, Nöthen MM, Schumacher J, Jäger A. Genome-wide transcriptome 
induced by Porphyromonas gingivalis LPS supports the notion of host-derived periodontal 
destruction and its association with systemic diseases. Innate Immun. 2016 Jan; 22(1):72-84. 
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AAM     alternatively activated macrophages  
APC     allophycocyanine  
BmA     Brugia malayi crude antigen extract 
BSA     bovine serum albumin 
°C     degree Celsius  
CCL / CCR    chemokine (c-c motif) ligand / receptor  
CD     cluster of differentiation 
CFU     colony forming units  
CXCL     chemokine C-X-C motif ligand 
CCL     CC-chemokine ligand 
DAMP     damage-associated molecular pattern 
DMSO     Dimethyl sulfoxide  
DNA     deoxyribonucleic acid  
Dpi     days post infection  
E/S     excretory/secretory  
EDTA     ethylenediaminetetraacetic acid  
ELISA     enzyme-linked immunosorbent assay  
FACS     Fluorescence activated cell sorting  
FCS     fetal calf serum  
FITC     Fluorescein isothiocyanate  
FMO     fluorescence minus one  
FSC     forward scatter  
Hi     high expressing  
IFN     interferon 
IL     Interleukin  
i.p.     Intra-peritoneal  
LF     lymphatic filariasis  
Lo     low expressing  
LPS     lipopolysaccharide  
LsAg     Litomosoides sigmodontis crude antigen extract 
MACS     magnet activated cell sorting  
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min     minute(s)  
mf     microfilariae  
MFI     mean fluorescence intensity  
MHC     mayor histocompatibility complex  
ml     milliliter  
MMP     matrix metalloproteinase 
MyD88    myeloid differentiation primary response protein 88  
o/n     over night  
P3C Pam3CSK4; Synthetic triacylated lipoprotein 
PAMP     pathogen-associated molecular pattern  
PBMC     peripheral blood mononuclear cells  
PBS     phosphate buffered saline  
PE     phycoerythrin  
PI     propidium iodide  
PRR     pattern recognition receptor  
RBC     red blood cell  
RELM     resistin-like molecule  
RNA     ribonucleic acid 
rpm     rounds per minute 
RT     room temperature  
SEM     standard error of mean  
SIRS     systemic inflammatory response syndrome  
SSC     side scatter  
Treg     regulatory T cell  
TGFβ     transforming growth factor beta  
Th     T helper cell  
TLR     Toll-like receptor  
TNF     tumor necrosis factor  
WHO     World Health Organisation 
WT     wild type  
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